<SEC-DOCUMENT>0001641172-25-026110.txt : 20250902
<SEC-HEADER>0001641172-25-026110.hdr.sgml : 20250902
<ACCEPTANCE-DATETIME>20250902060227
ACCESSION NUMBER:		0001641172-25-026110
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		17
CONFORMED PERIOD OF REPORT:	20250901
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250902
DATE AS OF CHANGE:		20250902

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Cyclacel Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001130166
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				911766850
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-50626
		FILM NUMBER:		251282779

	BUSINESS ADDRESS:	
		STREET 1:		200 CONNELL DRIVE
		STREET 2:		SUITE 1500
		CITY:			BERKELEY HEIGHTS
		STATE:			NJ
		ZIP:			07922
		BUSINESS PHONE:		908-517-7330

	MAIL ADDRESS:	
		STREET 1:		200 CONNELL DRIVE
		STREET 2:		SUITE 1500
		CITY:			BERKELEY HEIGHTS
		STATE:			NJ
		ZIP:			07922

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	XCYTE THERAPIES INC
		DATE OF NAME CHANGE:	20001218
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8-k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:us-roles="http://fasb.org/us-roles/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:CYCC="http://cyclacel.com/20250901">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02D_US%2DGAAP%2D2024 -->
<!-- Field: Set; Name: xdx; ID: xdx_039_CYCC_cyclacel.com_20250901 -->
<!-- Field: Set; Name: xdx; ID: xdx_048_20250901_20250901 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_058_edei%2D%2DEntityCentralIndexKey_0001130166 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2025-09-01" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-09-01" id="Fact000004" name="dei:EntityCentralIndexKey">0001130166</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="cycc-20250901.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2025-09-01">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001130166</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-09-01</xbrli:startDate>
        <xbrli:endDate>2025-09-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-09-012025-09-01_custom_CommonStockParValue0.001PerShareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001130166</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCC:CommonStockParValue0.001PerShareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-09-01</xbrli:startDate>
        <xbrli:endDate>2025-09-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-09-012025-09-01_custom_PreferredStock0.001ParValueMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001130166</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCC:PreferredStock0.001ParValueMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-09-01</xbrli:startDate>
        <xbrli:endDate>2025-09-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; width: 100%"><div style="border-top: Black 4pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>Washington,
DC 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>FORM
<span id="xdx_901_edei--DocumentType_c20250901__20250901_zgwX00cZYzK1"><ix:nonNumeric contextRef="AsOf2025-09-01" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CURRENT
REPORT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pursuant
to Section 13 or 15(d)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>of
the Securities Exchange Act of 1934</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90F_edei--DocumentPeriodEndDate_c20250901__20250901_z7IIZzgyT2f2"><ix:nonNumeric contextRef="AsOf2025-09-01" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">September
1, 2025</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date
of Report (date of earliest event reported)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="form8-k_001.jpg" alt=""/></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><span id="xdx_90A_edei--EntityRegistrantName_c20250901__20250901_zFSySlifsKkc"><ix:nonNumeric contextRef="AsOf2025-09-01" id="Fact000011" name="dei:EntityRegistrantName">Cyclacel
Pharmaceuticals, Inc.</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
name of Registrant as specified in its charter)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_907_edei--EntityIncorporationStateCountryCode_c20250901__20250901_z4Y0jd67vihc"><ix:nonNumeric contextRef="AsOf2025-09-01" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_904_edei--EntityFileNumber_c20250901__20250901_zePVKWFBHLfi"><ix:nonNumeric contextRef="AsOf2025-09-01" id="Fact000013" name="dei:EntityFileNumber">0-50626</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_901_edei--EntityTaxIdentificationNumber_c20250901__20250901_z82m4eoqgKx4"><ix:nonNumeric contextRef="AsOf2025-09-01" id="Fact000014" name="dei:EntityTaxIdentificationNumber">91-1707622</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
    or other jurisdiction of<br/>
    incorporation or organization)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission<br/>
    File Number)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S.
    Employer<br/>
    Identification Number)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span id="xdx_90C_edei--EntityAddressAddressLine1_c20250901__20250901_zp4NIyiXFfRg" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><ix:nonNumeric contextRef="AsOf2025-09-01" id="Fact000015" name="dei:EntityAddressAddressLine1">Level
10, Tower 11</ix:nonNumeric></b></span><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, <span id="xdx_909_edei--EntityAddressAddressLine2_c20250901__20250901_zWLwH4PTec35"><ix:nonNumeric contextRef="AsOf2025-09-01" id="Fact000016" name="dei:EntityAddressAddressLine2">Avenue 5, No. 8</ix:nonNumeric></span></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_905_edei--EntityAddressAddressLine3_c20250901__20250901_zsfZUafRKMr4"><ix:nonNumeric contextRef="AsOf2025-09-01" id="Fact000017" name="dei:EntityAddressAddressLine3">Jalan
Kerinchi</ix:nonNumeric></span>, <span id="xdx_90F_edei--EntityAddressCityOrTown_c20250901__20250901_zidOIaHvp4Ga"><ix:nonNumeric contextRef="AsOf2025-09-01" id="Fact000018" name="dei:EntityAddressCityOrTown">Kuala Lumpur</ix:nonNumeric></span>, <span id="xdx_90F_edei--EntityAddressCountry_c20250901__20250901_zDgQeHClbd57"><ix:nonNumeric contextRef="AsOf2025-09-01" format="ixt-sec:countrynameen" id="Fact000019" name="dei:EntityAddressCountry">Malaysia</ix:nonNumeric></span> <span id="xdx_90B_edei--EntityAddressPostalZipCode_c20250901__20250901_zkvUCxW7FKSk"><ix:nonNumeric contextRef="AsOf2025-09-01" id="Fact000020" name="dei:EntityAddressPostalZipCode">59200</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
of principal executive offices) (Zip code)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_901_edei--CityAreaCode_c20250901__20250901_zIF8Q8ZYi56"><ix:nonNumeric contextRef="AsOf2025-09-01" id="Fact000021" name="dei:CityAreaCode">(908)</ix:nonNumeric></span>
<span id="xdx_90B_edei--LocalPhoneNumber_c20250901__20250901_zmIEj6lgSVsc"><ix:nonNumeric contextRef="AsOf2025-09-01" id="Fact000022" name="dei:LocalPhoneNumber">517-7330</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Registrant&#8217;s
telephone number, including area code)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span>Not
Applicable</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Former
name or former address, if changed since last report)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions (see General Instruction A.2. below):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_edei--WrittenCommunications_c20250901__20250901_zzy4MPt9YJK9"><ix:nonNumeric contextRef="AsOf2025-09-01" format="ixt:booleanfalse" id="Fact000023" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written communications
    pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_edei--SolicitingMaterial_c20250901__20250901_zbfFDihhGfl9"><ix:nonNumeric contextRef="AsOf2025-09-01" format="ixt:booleanfalse" id="Fact000024" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting material pursuant
    to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_edei--PreCommencementTenderOffer_c20250901__20250901_zA4MtBmUYiV"><ix:nonNumeric contextRef="AsOf2025-09-01" format="ixt:booleanfalse" id="Fact000025" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement communications
    pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_edei--PreCommencementIssuerTenderOffer_c20250901__20250901_zmRXwM68Pxp6"><ix:nonNumeric contextRef="AsOf2025-09-01" format="ixt:booleanfalse" id="Fact000026" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement communications
    pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered pursuant to Section 12(b) of the Act:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 38%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title
    of each class</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trading
    Symbol(s)</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 38%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name
    of each exchange on which registered </b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_edei--Security12bTitle_c20250901__20250901__us-gaap--StatementClassOfStockAxis__custom--CommonStockParValue0.001PerShareMember_zwEqIcNEEl4k"><ix:nonNumeric contextRef="From2025-09-012025-09-01_custom_CommonStockParValue0.001PerShareMember" id="Fact000027" name="dei:Security12bTitle">Common Stock, par value
    $0.001 per share</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_edei--TradingSymbol_c20250901__20250901__us-gaap--StatementClassOfStockAxis__custom--CommonStockParValue0.001PerShareMember_zfeVn2LOM4o9"><ix:nonNumeric contextRef="From2025-09-012025-09-01_custom_CommonStockParValue0.001PerShareMember" id="Fact000028" name="dei:TradingSymbol">CYCC</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>The <span id="xdx_902_edei--SecurityExchangeName_c20250901__20250901__us-gaap--StatementClassOfStockAxis__custom--CommonStockParValue0.001PerShareMember_zCKuwLM0Il45"><ix:nonNumeric contextRef="From2025-09-012025-09-01_custom_CommonStockParValue0.001PerShareMember" format="ixt-sec:exchnameen" id="Fact000029" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Capital Market</span>
    </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_edei--Security12bTitle_c20250901__20250901__us-gaap--StatementClassOfStockAxis__custom--PreferredStock0.001ParValueMember_zwTGFUQpVOC4"><ix:nonNumeric contextRef="From2025-09-012025-09-01_custom_PreferredStock0.001ParValueMember" id="Fact000030" name="dei:Security12bTitle">Preferred Stock, $0.001
    par value</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_edei--TradingSymbol_c20250901__20250901__us-gaap--StatementClassOfStockAxis__custom--PreferredStock0.001ParValueMember_zGPz8Rd57Fpb"><ix:nonNumeric contextRef="From2025-09-012025-09-01_custom_PreferredStock0.001ParValueMember" id="Fact000031" name="dei:TradingSymbol">CYCCP</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>The <span id="xdx_909_edei--SecurityExchangeName_c20250901__20250901__us-gaap--StatementClassOfStockAxis__custom--PreferredStock0.001ParValueMember_zZV3x4Ar8op5"><ix:nonNumeric contextRef="From2025-09-012025-09-01_custom_PreferredStock0.001ParValueMember" format="ixt-sec:exchnameen" id="Fact000032" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Capital Market</span>
    </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
growth company <span id="xdx_90A_edei--EntityEmergingGrowthCompany_c20250901__20250901_zRIcS8nMOX2j"><ix:nonNumeric contextRef="AsOf2025-09-01" format="ixt:booleanfalse" id="Fact000033" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 4pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Item
1.01. Entry into a Material Definitive Agreement.</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 1, 2025, Cyclacel Pharmaceuticals, Inc. (the &#8220;Company&#8221;) issued amended and restated series A common stock
purchase warrants, amended and restated series B common stock purchase warrants and amended and restated series C common stock purchase
warrants (collectively, the &#8220;Amended Warrants&#8221;) <span style="background-color: white">to</span> holders of the Amended Warrants
whereby the Company removed the Ownership Limitation (as defined below). The removal of the Ownership Limitation was approved by the
Board of Directors and majority stockholder of the Company as disclosed in the Company&#8217;s Definitive Information Statement on Schedule
14C filed with the Securities and Exchange Commission on July 7, 2025, with an effective date of July 28, 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
described in the Schedule 14C, the original Warrants could not be exercised in a manner that would result in the holder or his or her
transferees or their affiliates holding or voting more than the lower of (i) the maximum percentage of the number of shares of common
stock outstanding immediately after giving effect to the issuance of shares of common stock issuable upon exercise of the original Warrants
that could be issued to the holder without requiring a vote of the stockholders of the Company under the rules and regulations of The
Nasdaq Capital Market, and (ii) 4.99% of the number of shares of common stock outstanding immediately before the original issue date,
prior to the date that the Company&#8217;s stockholders approved the issuance of shares of common stock to the holder thereof (the &#8220;Ownership
Limitation&#8221;). The Amended Warrants removes such Ownership Limitation such that the Amended Warrants may be exercised and voted
without regard to such Ownership Limitation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
amended and restated series A common stock purchase warrants entitle each holder to purchase 218,000 shares of common stock of the Company
at an exercise price of $7.65 per share with an expiration date five years from the date of issuance. The amended and restated series
B common stock purchase warrants entitle each holder to purchase 218,000 shares of common stock of the Company at an exercise price of
$9.00 per share with an expiration date five years from the date of issuance. The amended and restated series C common stock purchase
warrants entitle each holder to purchase 218,000 shares of common stock of the Company at an exercise price of $10.20 per share with
an expiration date five years from the date of issuance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing description of the Amended Warrants do not purport to be complete and are qualified in their entirety by reference to the full
text of the Amended Warrants which are filed as Exhibits 10.1, 10.2 and 10.3 respectively, to this Current Report on Form 8-K and incorporated
herein by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Item
9.01. Financial Statements and Exhibits.</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<i>Exhibits.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit
    No.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex10-1.htm">Form of Amended and Restated Series A Common Stock Purchase Warrant</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex10-2.htm">Form of Amended and Restated Series B Common Stock Purchase Warrant</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex10-3.htm">Form of Amended and Restated Series C Common Stock Purchase Warrant</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover Page Interactive
    Data File (embedded within the XBRL document)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNATURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    September 1, 2025</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cyclacel Pharmaceuticals, Inc.</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Datuk Dr. Doris Wong Sing Ee</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Datuk Dr. Doris
    Wong Sing Ee</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer
    and Executive Director</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 3; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJx1kd9qwjAUh5+g73AouxRNK47Ru604GaujVBFvY3vcgm1OOUmdPtLecmm6upstBEKS33e+/AnDSbiiZ1Ujw/6pyGCLTVtLi1DgERl1iS6Rvrwm4MYC35WxLLX10xFMyTHomPtpdHDrPnlWBqsExMNsLmbxAsQimQvI12HQ76ekj6pCbZWsQeoKcqaWFVrJ16HCVl5IU3P1ph2yUaQTiKZi2P6CWEQxvNFZfhKfDGRZGgYT34JwxdS1LrW8WNQ9CcsaG6czA/3b/WnKzlhqkpz7OzNWG0vlSUyFiHLJO1l3uMbmgOyikYjjSDz+nOJGgEcmcOcpaCXDuef+sLjXakj7/Fh9UCFvPiT/pxqw0XMT3IzuH0yPj8Zvpn2K9Q== -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>ex10-1.htm
<DESCRIPTION>EX-10.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AMENDED
AND RESTATED</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SERIES
A COMMON STOCK PURCHASE WARRANT</B></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>CYCLACEL
PHARMACEUTICALS, inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 50%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant Shares: 218,000</FONT></TD><TD STYLE="text-align: justify; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initial
                                            Exercise Date: June 20, 2025</FONT></TD>
</TR><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Issue
                                            Date: September 1, 2025</FONT></TD></TR>
     </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 3.5in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
SERIES A COMMON STOCK PURCHASE WARRANT (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, _____________ or its assigns
(the &ldquo;<U>Holder</U>&rdquo;) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter
set forth, at any time on or after the date hereof (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) and on or prior to 5:00 p.m. (New
York City time) on June 20, 2030 (the &ldquo;<U>Termination Date</U>&rdquo;) but not thereafter, to subscribe for and purchase from Cyclacel
Pharmaceuticals, Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), up to 218,000 shares (as subject to adjustment hereunder,
the &ldquo;<U>Warrant Shares</U>&rdquo;) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be
equal to the Exercise Price, as defined in Section 2(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
1</U>. <U>Definitions</U>. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain
Securities Purchase Agreement (the &ldquo;<U>Purchase Agreement</U>&rdquo;), dated June 20, 2025, among the Company and the purchasers
signatory thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
2</U>. <U>Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Exercise of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time
or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed PDF
copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the &ldquo;<U>Notice of Exercise</U>&rdquo;).
Within the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined
in Section 2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the
shares specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United States bank unless
the cashless exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise. No ink-original Notice
of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise
be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to
the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full,
in which case, the Holder shall surrender this Warrant to the Company for cancellation within three (3) Trading Days of the date on which
the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the
total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable
hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records
showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice
of Exercise on the Trading Day of receipt of such notice. <B>The Holder and any assignee, by acceptance of this Warrant, acknowledge
and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the
number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Exercise Price</U>. The exercise price per share of Common Stock under this Warrant shall be <B>$</B>7.65, subject to adjustment hereunder
(the &ldquo;<U>Exercise Price</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Cashless Exercise</U>. If at the time of exercise hereof there is no effective registration statement registering, or the prospectus
contained therein is not available for the issuance of the Warrant Shares to the Holder, then this Warrant may also be exercised, in
whole or in part, at such time by means of a &ldquo;cashless exercise&rdquo; in which the Holder shall be entitled to receive a number
of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in; text-align: left"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(A)</FONT></TD>
    <TD STYLE="width: 0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif">=</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">as
                                    applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice
                                    of Exercise if such Notice of Exercise is (1) delivered pursuant to Section 2(a) hereof on a day
                                    that is not a Trading Day or (2) delivered pursuant to Section 2(a) hereof on a Trading Day prior
                                    to the opening of &ldquo;regular trading hours&rdquo; (as defined in Rule 600(b) of Regulation NMS
                                    promulgated under the federal securities laws) on such Trading Day, (ii) the highest Bid Price of
                                    the Common Stock on the principal Trading Market as reported by Bloomberg L.P. (&ldquo;<U>Bloomberg</U>&rdquo;)
                                    within two (2) hours of the time of the Holder&rsquo;s delivery of the Notice of Exercise pursuant
                                    to Section 2(a) hereof if such Notice of Exercise is delivered during &ldquo;regular trading hours,&rdquo;
                                    or within two (2) hours after the close of &ldquo;regular trading hours&rdquo; on a Trading Day or
                                    (iii) the VWAP on the date of the applicable Notice of Exercise if the date of such Notice of Exercise
                                    is a Trading Day and such Notice of Exercise is delivered pursuant to Section 2(a) hereof after two
                                    (2) hours following the close of &ldquo;regular trading hours&rdquo; on such Trading Day;</FONT></TD>
</TR><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">(B)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">=</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the Exercise Price of this Warrant,
              as adjusted hereunder; and</FONT></TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">(X)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">=</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the number of
              Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such
              exercise were by means of a cash exercise rather than a cashless exercise.</FONT></TD></TR>
     </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 103.5pt; text-align: justify; text-indent: -31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">If
Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the
Securities Act, the Warrant Shares shall take on the registered characteristics of the Warrants being exercised. The Company agrees not
to take any position contrary to this Section 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Bid
Price</U>&rdquo; means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock
is then listed or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.
(New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average price
of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then
listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (or a similar
organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported,
or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good
faith by the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees
and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed
or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.
(New York City time) to 4:02 p.m. (New York City time)), (b) if the OTCQB Venture Market (&ldquo;<U>OTCQB</U>&rdquo;) or the OTCQX Best
Market (&ldquo;<U>OTCQX</U>&rdquo;) is not a Trading Market, the volume weighted average price of the Common Stock for such date (or
the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed or quoted for trading on OTCQB
or OTCQX and if prices for the Common Stock are then reported on the Pink Open Market (&ldquo;<U>Pink Market</U>&rdquo;) operated by
the OTC Markets, Inc. (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price
per share of the Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined
by an independent appraiser selected in good faith by the Purchasers of a majority in interest of the Securities then outstanding and
reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Mechanics of Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
<U>Delivery of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by
the Transfer Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository
Trust Company through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a participant
in such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale
of the Warrant Shares by Holder or (B) this Warrant is being exercised via cashless exercise, and otherwise by physical delivery of a
certificate, registered in the Company&rsquo;s share register in the name of the Holder or its designee, for the number of Warrant Shares
to which the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date
that is the earlier of (i) one (1) Trading Day after the delivery to the Company of the Notice of Exercise and (ii) the number of Trading
Days comprising the Standard Settlement Period after the delivery to the Company of the Notice of Exercise (such date, the &ldquo;<U>Warrant
Share Delivery Date</U>&rdquo;). Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have
become the holder of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of
delivery of the Warrant Shares, provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise)
is received within the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period
following delivery of the Notice of Exercise. If the Company fails for any reason to deliver to the Holder the Warrant Shares subject
to a Notice of Exercise by the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not
as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Stock on the date of the applicable
Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on the third Trading Day after the Warrant Share Delivery
Date) for each Trading Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise.
The Company agrees to maintain a transfer agent that is a participant in the FAST program so long as this Warrant remains outstanding
and exercisable. As used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo; means the standard settlement period, expressed in a
number of Trading Days, on the Company&rsquo;s primary Trading Market with respect to the Common Stock as in effect on the date of delivery
of the Notice of Exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
<U>Delivery of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of
a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant
evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in
all other respects be identical with this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.
<U>Rescission Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section
2(d)(i) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.
<U>Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to
the Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions
of Section 2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required
by its broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares
of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon
such exercise (a &ldquo;<U>Buy-In</U>&rdquo;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x)
the Holder&rsquo;s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds
(y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection
with the exercise at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B)
at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise
was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock
that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the
Holder purchases Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares
of Common Stock with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately
preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating
the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing
herein shall limit a Holder&rsquo;s right to pursue any other remedies available to it hereunder, at law or in equity including, without
limitation, a decree of specific performance and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares
of Common Stock upon exercise of the Warrant as required pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">v.
<U>No Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise
of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company
shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied
by the Exercise Price or round up to the next whole share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vi.
<U>Charges, Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax
or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company,
and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>,
<U>however</U>, that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when
surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may
require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company
shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company
(or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vii.
<U>Closing of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise
of this Warrant, pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Reserved</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
3</U>. <U>Certain Adjustments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Stock Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise
makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares
of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the
Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which
the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of
shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant
shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for
the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the
effective date in the case of a subdivision, combination or re-classification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Subsequent Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants,
issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record
holders of any class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to acquire,
upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had
held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise
hereof) immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such
record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the grant, issue or sale
of such Purchase Rights.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Pro Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or
other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital
or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend,
spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;),
at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution
to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable
upon complete exercise of this Warrant (without regard to any limitations on exercise hereof) immediately before the date of which a
record is taken for such Distribution, or, if no such record is taken, the date as of which the record holders of shares of Common Stock
are to be determined for the participation in such Distribution. To the extent that this Warrant has not been partially or completely
exercised at the time of such Distribution, such portion of the Distribution shall be held in abeyance for the benefit of the Holder
until the Holder has exercised this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Fundamental Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or
more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company or any Subsidiary,
directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially
all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange
offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender
or exchange their shares for other securities, cash or property and has been accepted by the holders of greater than 50% of the outstanding
Common Stock or greater than 50% of the voting power of the common equity of the Company, (iv) the Company, directly or indirectly, in
one or more related transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory
share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property,
or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other
business combination (including, without limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with
another Person or group of Persons whereby such other Person or group acquires greater than 50% of the outstanding shares of Common Stock
or greater than 50% of the voting power of the common equity of the Company (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then,
upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been
issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without
regard to any limitation in Section 2(e) on the exercise of this Warrant), the number of shares of Common Stock of the successor or acquiring
corporation or of the Company, if it is the surviving corporation, and any additional consideration (the &ldquo;<U>Alternate Consideration</U>&rdquo;)
receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant is
exercisable immediately prior to such Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise of this
Warrant). For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such
Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental
Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the
relative value of any different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the
securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate
Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction. The Company shall cause any successor
entity in a Fundamental Transaction in which the Company is not the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;) to assume in
writing all of the obligations of the Company under this Warrant and the other Transaction Documents in accordance with the provisions
of this Section 3(d) pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder
(without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange
for this Warrant a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to
this Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity)
equivalent to the shares of Common Stock acquirable and receivable upon exercise of this Warrant (without regard to any limitations on
the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder
to such shares of capital stock (but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental
Transaction and the value of such shares of capital stock, such number of shares of capital stock and such exercise price being for the
purpose of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and
which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor
Entity shall be added to the term &ldquo;Company&rdquo; under this Warrant (so that from and after the occurrence or consummation of
such Fundamental Transaction, each and every provision of this Warrant and the other Transaction Documents referring to the &ldquo;Company&rdquo;
shall refer instead to each of the Company and the Successor Entity or Successor Entities, jointly and severally), and the Successor
Entity or Successor Entities, jointly and severally with the Company, may exercise every right and power of the Company prior thereto
and the Successor Entity or Successor Entities shall assume all of the obligations of the Company prior thereto under this Warrant and
the other Transaction Documents with the same effect as if the Company and such Successor Entity or Successor Entities, jointly and severally,
had been named as the Company herein. For the avoidance of doubt, the Holder shall be entitled to the benefits of the provisions of this
Section 3(d) regardless of (i) whether the Company has sufficient authorized shares of Common Stock for the issuance of Warrant Shares
and/or (ii) whether a Fundamental Transaction occurs prior to the Initial Exercise Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Reserved</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)
<U>Reserved</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)
<U>Calculations</U>. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the
case may be. For purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date
shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h)
<U>Notice to Holder</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
<U>Adjustment to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company
shall promptly deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment
to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
<U>Notice to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on
the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the
Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of
capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with
any reclassification of the Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries) is a party, any
sale or transfer of all or substantially all of its assets, or any compulsory share exchange whereby the Common Stock is converted into
other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding
up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by email to the Holder at its last email
address as it shall appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record or effective
date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution,
redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to
be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification,
consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected
that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other
property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to
deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to
be specified in such notice. To the extent that any notice provided in this Warrant constitutes, or contains, material, non-public information
regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a
Current Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such
notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i)
<U>Voluntary Adjustment By Company</U>. Subject to the rules and regulations of the Trading Market, the Company may at any time during
the term of this Warrant reduce the then current Exercise Price to any amount and for any period of time deemed appropriate by the board
of directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
4</U>. <U>Transfer of Warrant</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Transferability</U>. This Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable,
in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written
assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient
to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall
execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations
specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not
so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required
to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall
surrender this Warrant to the Company within three (3) Trading Days of the date on which the Holder delivers an assignment form to the
Company assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for
the purchase of Warrant Shares without having a new Warrant issued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>New Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of
the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by
the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division
or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided
or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the initial issuance date of
this Warrant and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Warrant Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the
&ldquo;<U>Warrant Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the
registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder,
and for all other purposes, absent actual notice to the contrary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
5</U>. <U>Miscellaneous</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>No Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights,
dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly
set forth in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant
to Section 2(c) or to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event shall the Company be
required to net cash settle an exercise of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Loss, Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares,
and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant,
shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the
Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant
or stock certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Saturdays, Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required
or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business
Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Authorized Shares</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a
sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant.
The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with
the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all
such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any
applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants
that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise
of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly
issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof
(other than taxes in respect of any transfer occurring contemporaneously with such issue).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending
its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale
of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant,
but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary
or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the
foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise
immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company
may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially
reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof,
as may be, necessary to enable the Company to perform its obligations under this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Before
taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the
Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from
any public regulatory body or bodies having jurisdiction thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Jurisdiction</U>. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined
in accordance with the provisions of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)
<U>Restrictions</U>. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and
the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)
<U>Nonwaiver and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall
operate as a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision
of this Warrant or the Purchase Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant,
which results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover
any costs and expenses including, but not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred
by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h)
<U>Notices</U>. Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall
be delivered in accordance with the notice provisions of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i)
<U>Limitation of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant
to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of
the Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company
or by creditors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">j)
<U>Remedies</U>. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will
be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate
compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to
assert the defense in any action for specific performance that a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">k)
<U>Successors and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall
inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns
of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall
be enforceable by the Holder or holder of Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">l)
<U>Amendment</U>. This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and
the Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">m)
<U>Severability</U>. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid
under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall
be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining
provisions of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">n)
<U>Headings</U>. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed
a part of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">********************</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Signature
Page Follows)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above
indicated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>CYCLACEL
    PHARMACEUTICALS, inc.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Datuk
    Dr. Doris Wong</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTICE
OF EXERCISE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">To:</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">CYCLACEL
                                            PHARMACEUTICALS, inc.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only
if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
Payment shall take the form of (check applicable box):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;
] in lawful money of the United States; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;
] [if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection
2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure
set forth in subsection 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrant Shares shall be delivered to the following DWAC Account Number:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Investing Entity: _____________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
of Authorized Signatory of Investing Entity</I>: _________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Authorized Signatory: ___________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
of Authorized Signatory: ____________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
________________________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
B</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">ASSIGNMENT
FORM</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(To
assign the foregoing Warrant, execute this form and supply required information. Do not use this form to purchase shares.)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: justify"></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
                                            Print)</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone
    Number:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email
    Address:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
    _______________ __, __________</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Signature: _________________________</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Address: __________________________</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>ex10-2.htm
<DESCRIPTION>EX-10.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit 10.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AMENDED
AND RESTATED</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SERIES
B COMMON STOCK PURCHASE WARRANT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>CYCLACEL
PHARMACEUTICALS, inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 50%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant Shares: 218,000</FONT></TD><TD STYLE="text-align: justify; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initial
                                            Exercise Date: June 20, 2025</FONT></TD>
</TR><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Issue
                                            Date: September 1, 2025</FONT></TD></TR>
     </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 3.5in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
SERIES B COMMON STOCK PURCHASE WARRANT (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, _____________ or its assigns
(the &ldquo;<U>Holder</U>&rdquo;) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter
set forth, at any time on or after the date hereof (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) and on or prior to 5:00 p.m. (New
York City time) on June 20, 2030 (the &ldquo;<U>Termination Date</U>&rdquo;) but not thereafter, to subscribe for and purchase from Cyclacel
Pharmaceuticals, Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), up to 218,000 shares (as subject to adjustment hereunder,
the &ldquo;<U>Warrant Shares</U>&rdquo;) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be
equal to the Exercise Price, as defined in Section 2(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
1</U>. <U>Definitions</U>. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain
Securities Purchase Agreement (the &ldquo;<U>Purchase Agreement</U>&rdquo;), dated June 20, 2025, among the Company and the purchasers
signatory thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
2</U>. <U>Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Exercise of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time
or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed PDF
copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the &ldquo;<U>Notice of Exercise</U>&rdquo;).
Within the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined
in Section 2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the
shares specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United States bank unless
the cashless exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise. No ink-original Notice
of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise
be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to
the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full,
in which case, the Holder shall surrender this Warrant to the Company for cancellation within three (3) Trading Days of the date on which
the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the
total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable
hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records
showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice
of Exercise on the Trading Day of receipt of such notice. <B>The Holder and any assignee, by acceptance of this Warrant, acknowledge
and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the
number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Exercise Price</U>. The exercise price per share of Common Stock under this Warrant shall be <B>$</B>9.00, subject to adjustment hereunder
(the &ldquo;<U>Exercise Price</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Cashless Exercise</U>. If at the time of exercise hereof there is no effective registration statement registering, or the prospectus
contained therein is not available for the issuance of the Warrant Shares to the Holder, then this Warrant may also be exercised, in
whole or in part, at such time by means of a &ldquo;cashless exercise&rdquo; in which the Holder shall be entitled to receive a number
of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in; text-align: left"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(A)</FONT></TD>
    <TD STYLE="width: 0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif">=</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">as
                                    applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice
                                    of Exercise if such Notice of Exercise is (1) delivered pursuant to Section 2(a) hereof on a day
                                    that is not a Trading Day or (2) delivered pursuant to Section 2(a) hereof on a Trading Day prior
                                    to the opening of &ldquo;regular trading hours&rdquo; (as defined in Rule 600(b) of Regulation NMS
                                    promulgated under the federal securities laws) on such Trading Day, (ii) the highest Bid Price of
                                    the Common Stock on the principal Trading Market as reported by Bloomberg L.P. (&ldquo;<U>Bloomberg</U>&rdquo;)
                                    within two (2) hours of the time of the Holder&rsquo;s delivery of the Notice of Exercise pursuant
                                    to Section 2(a) hereof if such Notice of Exercise is delivered during &ldquo;regular trading hours,&rdquo;
                                    or within two (2) hours after the close of &ldquo;regular trading hours&rdquo; on a Trading Day or
                                    (iii) the VWAP on the date of the applicable Notice of Exercise if the date of such Notice of Exercise
                                    is a Trading Day and such Notice of Exercise is delivered pursuant to Section 2(a) hereof after two
                                    (2) hours following the close of &ldquo;regular trading hours&rdquo; on such Trading Day;</FONT></TD>
</TR><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">(B)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">=</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the Exercise Price of this Warrant,
              as adjusted hereunder; and</FONT></TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">(X)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">=</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the number of
              Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such
              exercise were by means of a cash exercise rather than a cashless exercise.</FONT></TD></TR>
     </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 103.5pt; text-align: justify; text-indent: -31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">If
Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the
Securities Act, the Warrant Shares shall take on the registered characteristics of the Warrants being exercised. The Company agrees not
to take any position contrary to this Section 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Bid
Price</U>&rdquo; means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock
is then listed or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.
(New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average price
of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then
listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (or a similar
organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported,
or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good
faith by the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees
and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed
or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.
(New York City time) to 4:02 p.m. (New York City time)), (b) if the OTCQB Venture Market (&ldquo;<U>OTCQB</U>&rdquo;) or the OTCQX Best
Market (&ldquo;<U>OTCQX</U>&rdquo;) is not a Trading Market, the volume weighted average price of the Common Stock for such date (or
the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed or quoted for trading on OTCQB
or OTCQX and if prices for the Common Stock are then reported on the Pink Open Market (&ldquo;<U>Pink Market</U>&rdquo;) operated by
the OTC Markets, Inc. (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price
per share of the Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined
by an independent appraiser selected in good faith by the Purchasers of a majority in interest of the Securities then outstanding and
reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Mechanics of Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
<U>Delivery of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by
the Transfer Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository
Trust Company through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a participant
in such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale
of the Warrant Shares by Holder or (B) this Warrant is being exercised via cashless exercise, and otherwise by physical delivery of a
certificate, registered in the Company&rsquo;s share register in the name of the Holder or its designee, for the number of Warrant Shares
to which the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date
that is the earlier of (i) one (1) Trading Day after the delivery to the Company of the Notice of Exercise and (ii) the number of Trading
Days comprising the Standard Settlement Period after the delivery to the Company of the Notice of Exercise (such date, the &ldquo;<U>Warrant
Share Delivery Date</U>&rdquo;). Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have
become the holder of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of
delivery of the Warrant Shares, provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise)
is received within the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period
following delivery of the Notice of Exercise. If the Company fails for any reason to deliver to the Holder the Warrant Shares subject
to a Notice of Exercise by the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not
as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Stock on the date of the applicable
Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on the third Trading Day after the Warrant Share Delivery
Date) for each Trading Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise.
The Company agrees to maintain a transfer agent that is a participant in the FAST program so long as this Warrant remains outstanding
and exercisable. As used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo; means the standard settlement period, expressed in a
number of Trading Days, on the Company&rsquo;s primary Trading Market with respect to the Common Stock as in effect on the date of delivery
of the Notice of Exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
<U>Delivery of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of
a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant
evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in
all other respects be identical with this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.
<U>Rescission Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section
2(d)(i) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.
<U>Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to
the Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions
of Section 2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required
by its broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares
of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon
such exercise (a &ldquo;<U>Buy-In</U>&rdquo;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x)
the Holder&rsquo;s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds
(y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection
with the exercise at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B)
at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise
was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock
that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the
Holder purchases Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares
of Common Stock with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately
preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating
the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing
herein shall limit a Holder&rsquo;s right to pursue any other remedies available to it hereunder, at law or in equity including, without
limitation, a decree of specific performance and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares
of Common Stock upon exercise of the Warrant as required pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">v.
<U>No Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise
of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company
shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied
by the Exercise Price or round up to the next whole share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vi.
<U>Charges, Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax
or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company,
and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>,
<U>however</U>, that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when
surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may
require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company
shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company
(or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vii.
<U>Closing of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise
of this Warrant, pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Reserved</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
3</U>. <U>Certain Adjustments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Stock Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise
makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares
of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the
Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which
the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of
shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant
shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for
the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the
effective date in the case of a subdivision, combination or re-classification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Subsequent Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants,
issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record
holders of any class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to acquire,
upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had
held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise
hereof) immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such
record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the grant, issue or sale
of such Purchase Rights.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Pro Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or
other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital
or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend,
spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;),
at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution
to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable
upon complete exercise of this Warrant (without regard to any limitations on exercise hereof) immediately before the date of which a
record is taken for such Distribution, or, if no such record is taken, the date as of which the record holders of shares of Common Stock
are to be determined for the participation in such Distribution. To the extent that this Warrant has not been partially or completely
exercised at the time of such Distribution, such portion of the Distribution shall be held in abeyance for the benefit of the Holder
until the Holder has exercised this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Fundamental Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or
more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company or any Subsidiary,
directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially
all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange
offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender
or exchange their shares for other securities, cash or property and has been accepted by the holders of greater than 50% of the outstanding
Common Stock or greater than 50% of the voting power of the common equity of the Company, (iv) the Company, directly or indirectly, in
one or more related transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory
share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property,
or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other
business combination (including, without limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with
another Person or group of Persons whereby such other Person or group acquires greater than 50% of the outstanding shares of Common Stock
or greater than 50% of the voting power of the common equity of the Company (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then,
upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been
issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without
regard to any limitation in Section 2(e) on the exercise of this Warrant), the number of shares of Common Stock of the successor or acquiring
corporation or of the Company, if it is the surviving corporation, and any additional consideration (the &ldquo;<U>Alternate Consideration</U>&rdquo;)
receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant is
exercisable immediately prior to such Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise of this
Warrant). For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such
Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental
Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the
relative value of any different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the
securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate
Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction. The Company shall cause any successor
entity in a Fundamental Transaction in which the Company is not the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;) to assume in
writing all of the obligations of the Company under this Warrant and the other Transaction Documents in accordance with the provisions
of this Section 3(d) pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder
(without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange
for this Warrant a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to
this Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity)
equivalent to the shares of Common Stock acquirable and receivable upon exercise of this Warrant (without regard to any limitations on
the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder
to such shares of capital stock (but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental
Transaction and the value of such shares of capital stock, such number of shares of capital stock and such exercise price being for the
purpose of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and
which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor
Entity shall be added to the term &ldquo;Company&rdquo; under this Warrant (so that from and after the occurrence or consummation of
such Fundamental Transaction, each and every provision of this Warrant and the other Transaction Documents referring to the &ldquo;Company&rdquo;
shall refer instead to each of the Company and the Successor Entity or Successor Entities, jointly and severally), and the Successor
Entity or Successor Entities, jointly and severally with the Company, may exercise every right and power of the Company prior thereto
and the Successor Entity or Successor Entities shall assume all of the obligations of the Company prior thereto under this Warrant and
the other Transaction Documents with the same effect as if the Company and such Successor Entity or Successor Entities, jointly and severally,
had been named as the Company herein. For the avoidance of doubt, the Holder shall be entitled to the benefits of the provisions of this
Section 3(d) regardless of (i) whether the Company has sufficient authorized shares of Common Stock for the issuance of Warrant Shares
and/or (ii) whether a Fundamental Transaction occurs prior to the Initial Exercise Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Reserved</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)
<U>Reserved</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)
<U>Calculations</U>. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the
case may be. For purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date
shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h)
<U>Notice to Holder</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
<U>Adjustment to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company
shall promptly deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment
to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
<U>Notice to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on
the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the
Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of
capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with
any reclassification of the Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries) is a party, any
sale or transfer of all or substantially all of its assets, or any compulsory share exchange whereby the Common Stock is converted into
other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding
up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by email to the Holder at its last email
address as it shall appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record or effective
date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution,
redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to
be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification,
consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected
that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other
property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to
deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to
be specified in such notice. To the extent that any notice provided in this Warrant constitutes, or contains, material, non-public information
regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a
Current Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such
notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i)
<U>Voluntary Adjustment By Company</U>. Subject to the rules and regulations of the Trading Market, the Company may at any time during
the term of this Warrant reduce the then current Exercise Price to any amount and for any period of time deemed appropriate by the board
of directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
4</U>. <U>Transfer of Warrant</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Transferability</U>. This Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable,
in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written
assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient
to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall
execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations
specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not
so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required
to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall
surrender this Warrant to the Company within three (3) Trading Days of the date on which the Holder delivers an assignment form to the
Company assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for
the purchase of Warrant Shares without having a new Warrant issued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>New Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of
the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by
the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division
or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided
or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the initial issuance date of
this Warrant and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Warrant Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the
&ldquo;<U>Warrant Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the
registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder,
and for all other purposes, absent actual notice to the contrary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
5</U>. <U>Miscellaneous</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>No Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights,
dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly
set forth in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant
to Section 2(c) or to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event shall the Company be
required to net cash settle an exercise of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Loss, Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares,
and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant,
shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the
Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant
or stock certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Saturdays, Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required
or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business
Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Authorized Shares</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a
sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant.
The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with
the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all
such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any
applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants
that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise
of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly
issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof
(other than taxes in respect of any transfer occurring contemporaneously with such issue).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending
its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale
of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant,
but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary
or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the
foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise
immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company
may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially
reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof,
as may be, necessary to enable the Company to perform its obligations under this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Before
taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the
Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from
any public regulatory body or bodies having jurisdiction thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Jurisdiction</U>. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined
in accordance with the provisions of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)
<U>Restrictions</U>. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and
the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)
<U>Nonwaiver and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall
operate as a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision
of this Warrant or the Purchase Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant,
which results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover
any costs and expenses including, but not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred
by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h)
<U>Notices</U>. Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall
be delivered in accordance with the notice provisions of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i)
<U>Limitation of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant
to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of
the Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company
or by creditors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">j)
<U>Remedies</U>. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will
be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate
compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to
assert the defense in any action for specific performance that a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">k)
<U>Successors and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall
inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns
of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall
be enforceable by the Holder or holder of Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">l)
<U>Amendment</U>. This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and
the Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">m)
<U>Severability</U>. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid
under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall
be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining
provisions of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">n)
<U>Headings</U>. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed
a part of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">********************</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Signature
Page Follows)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above
indicated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>CYCLACEL
    PHARMACEUTICALS, inc.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Datuk
    Dr. Doris Wong</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTICE
OF EXERCISE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">To:</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">CYCLACEL
                                            PHARMACEUTICALS, inc.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only
if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
Payment shall take the form of (check applicable box):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;
] in lawful money of the United States; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;
] [if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection
2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure
set forth in subsection 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrant Shares shall be delivered to the following DWAC Account Number:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Investing Entity: _____________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
of Authorized Signatory of Investing Entity</I>: _________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Authorized Signatory: ___________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
of Authorized Signatory: ____________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
________________________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
B</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">ASSIGNMENT
FORM</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(To
assign the foregoing Warrant, execute this form and supply required information. Do not use this form to purchase shares.)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: justify"></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
                                            Print)</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone
    Number:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email
    Address:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
    _______________ __, __________</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Signature: _________________________</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Address: __________________________</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>4
<FILENAME>ex10-3.htm
<DESCRIPTION>EX-10.3
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit 10.3</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AMENDED
AND RESTATED</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SERIES
C COMMON STOCK PURCHASE WARRANT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>CYCLACEL
PHARMACEUTICALS, inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 50%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant Shares: 218,000</FONT></TD><TD STYLE="text-align: justify; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initial
                                            Exercise Date: June 20, 2025</FONT></TD>
</TR><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Issue
                                            Date: September 1, 2025</FONT></TD></TR>
     </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 3.5in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
SERIES C COMMON STOCK PURCHASE WARRANT (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, _____________ or its assigns
(the &ldquo;<U>Holder</U>&rdquo;) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter
set forth, at any time on or after the date hereof (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) and on or prior to 5:00 p.m. (New
York City time) on June 20, 2030 (the &ldquo;<U>Termination Date</U>&rdquo;) but not thereafter, to subscribe for and purchase from Cyclacel
Pharmaceuticals, Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), up to 218,000 shares (as subject to adjustment hereunder,
the &ldquo;<U>Warrant Shares</U>&rdquo;) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be
equal to the Exercise Price, as defined in Section 2(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
1</U>. <U>Definitions</U>. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain
Securities Purchase Agreement (the &ldquo;<U>Purchase Agreement</U>&rdquo;), dated June 20, 2025, among the Company and the purchasers
signatory thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
2</U>. <U>Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Exercise of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time
or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed PDF
copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the &ldquo;<U>Notice of Exercise</U>&rdquo;).
Within the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined
in Section 2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the
shares specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United States bank unless
the cashless exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise. No ink-original Notice
of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise
be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to
the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full,
in which case, the Holder shall surrender this Warrant to the Company for cancellation within three (3) Trading Days of the date on which
the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the
total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable
hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records
showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice
of Exercise on the Trading Day of receipt of such notice. <B>The Holder and any assignee, by acceptance of this Warrant, acknowledge
and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the
number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Exercise Price</U>. The exercise price per share of Common Stock under this Warrant shall be <B>$</B>10.20, subject to adjustment hereunder
(the &ldquo;<U>Exercise Price</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Cashless Exercise</U>. If at the time of exercise hereof there is no effective registration statement registering, or the prospectus
contained therein is not available for the issuance of the Warrant Shares to the Holder, then this Warrant may also be exercised, in
whole or in part, at such time by means of a &ldquo;cashless exercise&rdquo; in which the Holder shall be entitled to receive a number
of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in; text-align: left"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(A)</FONT></TD>
    <TD STYLE="width: 0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif">=</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">as
                                    applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice
                                    of Exercise if such Notice of Exercise is (1) delivered pursuant to Section 2(a) hereof on a day
                                    that is not a Trading Day or (2) delivered pursuant to Section 2(a) hereof on a Trading Day prior
                                    to the opening of &ldquo;regular trading hours&rdquo; (as defined in Rule 600(b) of Regulation NMS
                                    promulgated under the federal securities laws) on such Trading Day, (ii) the highest Bid Price of
                                    the Common Stock on the principal Trading Market as reported by Bloomberg L.P. (&ldquo;<U>Bloomberg</U>&rdquo;)
                                    within two (2) hours of the time of the Holder&rsquo;s delivery of the Notice of Exercise pursuant
                                    to Section 2(a) hereof if such Notice of Exercise is delivered during &ldquo;regular trading hours,&rdquo;
                                    or within two (2) hours after the close of &ldquo;regular trading hours&rdquo; on a Trading Day or
                                    (iii) the VWAP on the date of the applicable Notice of Exercise if the date of such Notice of Exercise
                                    is a Trading Day and such Notice of Exercise is delivered pursuant to Section 2(a) hereof after two
                                    (2) hours following the close of &ldquo;regular trading hours&rdquo; on such Trading Day;</FONT></TD>
</TR><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">(B)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">=</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the Exercise Price of this Warrant,
              as adjusted hereunder; and</FONT></TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">(X)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">=</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the number of
              Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such
              exercise were by means of a cash exercise rather than a cashless exercise.</FONT></TD></TR>
     </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 103.5pt; text-align: justify; text-indent: -31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">If
Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the
Securities Act, the Warrant Shares shall take on the registered characteristics of the Warrants being exercised. The Company agrees not
to take any position contrary to this Section 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Bid
Price</U>&rdquo; means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock
is then listed or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.
(New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average price
of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then
listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (or a similar
organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported,
or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good
faith by the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees
and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed
or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.
(New York City time) to 4:02 p.m. (New York City time)), (b) if the OTCQB Venture Market (&ldquo;<U>OTCQB</U>&rdquo;) or the OTCQX Best
Market (&ldquo;<U>OTCQX</U>&rdquo;) is not a Trading Market, the volume weighted average price of the Common Stock for such date (or
the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed or quoted for trading on OTCQB
or OTCQX and if prices for the Common Stock are then reported on the Pink Open Market (&ldquo;<U>Pink Market</U>&rdquo;) operated by
the OTC Markets, Inc. (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price
per share of the Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined
by an independent appraiser selected in good faith by the Purchasers of a majority in interest of the Securities then outstanding and
reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Mechanics of Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
<U>Delivery of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by
the Transfer Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository
Trust Company through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a participant
in such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale
of the Warrant Shares by Holder or (B) this Warrant is being exercised via cashless exercise, and otherwise by physical delivery of a
certificate, registered in the Company&rsquo;s share register in the name of the Holder or its designee, for the number of Warrant Shares
to which the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date
that is the earlier of (i) one (1) Trading Day after the delivery to the Company of the Notice of Exercise and (ii) the number of Trading
Days comprising the Standard Settlement Period after the delivery to the Company of the Notice of Exercise (such date, the &ldquo;<U>Warrant
Share Delivery Date</U>&rdquo;). Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have
become the holder of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of
delivery of the Warrant Shares, provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise)
is received within the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period
following delivery of the Notice of Exercise. If the Company fails for any reason to deliver to the Holder the Warrant Shares subject
to a Notice of Exercise by the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not
as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Stock on the date of the applicable
Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on the third Trading Day after the Warrant Share Delivery
Date) for each Trading Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise.
The Company agrees to maintain a transfer agent that is a participant in the FAST program so long as this Warrant remains outstanding
and exercisable. As used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo; means the standard settlement period, expressed in a
number of Trading Days, on the Company&rsquo;s primary Trading Market with respect to the Common Stock as in effect on the date of delivery
of the Notice of Exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
<U>Delivery of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of
a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant
evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in
all other respects be identical with this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.
<U>Rescission Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section
2(d)(i) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.
<U>Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to
the Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions
of Section 2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required
by its broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares
of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon
such exercise (a &ldquo;<U>Buy-In</U>&rdquo;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x)
the Holder&rsquo;s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds
(y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection
with the exercise at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B)
at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise
was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock
that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the
Holder purchases Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares
of Common Stock with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately
preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating
the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing
herein shall limit a Holder&rsquo;s right to pursue any other remedies available to it hereunder, at law or in equity including, without
limitation, a decree of specific performance and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares
of Common Stock upon exercise of the Warrant as required pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">v.
<U>No Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise
of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company
shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied
by the Exercise Price or round up to the next whole share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vi.
<U>Charges, Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax
or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company,
and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>,
<U>however</U>, that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when
surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may
require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company
shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company
(or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vii.
<U>Closing of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise
of this Warrant, pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Reserved</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
3</U>. <U>Certain Adjustments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Stock Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise
makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares
of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the
Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which
the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of
shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant
shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for
the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the
effective date in the case of a subdivision, combination or re-classification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Subsequent Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants,
issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record
holders of any class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to acquire,
upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had
held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise
hereof) immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such
record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the grant, issue or sale
of such Purchase.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Pro Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or
other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital
or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend,
spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;),
at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution
to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable
upon complete exercise of this Warrant (without regard to any limitations on exercise hereof) immediately before the date of which a
record is taken for such Distribution, or, if no such record is taken, the date as of which the record holders of shares of Common Stock
are to be determined for the participation in such Distribution. To the extent that this Warrant has not been partially or completely
exercised at the time of such Distribution, such portion of the Distribution shall be held in abeyance for the benefit of the Holder
until the Holder has exercised this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Fundamental Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or
more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company or any Subsidiary,
directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially
all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange
offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender
or exchange their shares for other securities, cash or property and has been accepted by the holders of greater than 50% of the outstanding
Common Stock or greater than 50% of the voting power of the common equity of the Company, (iv) the Company, directly or indirectly, in
one or more related transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory
share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property,
or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other
business combination (including, without limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with
another Person or group of Persons whereby such other Person or group acquires greater than 50% of the outstanding shares of Common Stock
or greater than 50% of the voting power of the common equity of the Company (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then,
upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been
issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without
regard to any limitation in Section 2(e) on the exercise of this Warrant), the number of shares of Common Stock of the successor or acquiring
corporation or of the Company, if it is the surviving corporation, and any additional consideration (the &ldquo;<U>Alternate Consideration</U>&rdquo;)
receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant is
exercisable immediately prior to such Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise of this
Warrant). For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such
Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental
Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the
relative value of any different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the
securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate
Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction. The Company shall cause any successor
entity in a Fundamental Transaction in which the Company is not the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;) to assume in
writing all of the obligations of the Company under this Warrant and the other Transaction Documents in accordance with the provisions
of this Section 3(d) pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder
(without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange
for this Warrant a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to
this Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity)
equivalent to the shares of Common Stock acquirable and receivable upon exercise of this Warrant (without regard to any limitations on
the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder
to such shares of capital stock (but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental
Transaction and the value of such shares of capital stock, such number of shares of capital stock and such exercise price being for the
purpose of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and
which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor
Entity shall be added to the term &ldquo;Company&rdquo; under this Warrant (so that from and after the occurrence or consummation of
such Fundamental Transaction, each and every provision of this Warrant and the other Transaction Documents referring to the &ldquo;Company&rdquo;
shall refer instead to each of the Company and the Successor Entity or Successor Entities, jointly and severally), and the Successor
Entity or Successor Entities, jointly and severally with the Company, may exercise every right and power of the Company prior thereto
and the Successor Entity or Successor Entities shall assume all of the obligations of the Company prior thereto under this Warrant and
the other Transaction Documents with the same effect as if the Company and such Successor Entity or Successor Entities, jointly and severally,
had been named as the Company herein. For the avoidance of doubt, the Holder shall be entitled to the benefits of the provisions of this
Section 3(d) regardless of (i) whether the Company has sufficient authorized shares of Common Stock for the issuance of Warrant Shares
and/or (ii) whether a Fundamental Transaction occurs prior to the Initial Exercise Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Reserved</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)
<U>Reserved</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)
<U>Calculations</U>. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the
case may be. For purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date
shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h)
<U>Notice to Holder</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
<U>Adjustment to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company
shall promptly deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment
to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
<U>Notice to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on
the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the
Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of
capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with
any reclassification of the Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries) is a party, any
sale or transfer of all or substantially all of its assets, or any compulsory share exchange whereby the Common Stock is converted into
other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding
up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by email to the Holder at its last email
address as it shall appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record or effective
date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution,
redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to
be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification,
consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected
that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other
property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to
deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to
be specified in such notice. To the extent that any notice provided in this Warrant constitutes, or contains, material, non-public information
regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a
Current Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such
notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i)
<U>Voluntary Adjustment By Company</U>. Subject to the rules and regulations of the Trading Market, the Company may at any time during
the term of this Warrant reduce the then current Exercise Price to any amount and for any period of time deemed appropriate by the board
of directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
4</U>. <U>Transfer of Warrant</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Transferability</U>. This Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable,
in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written
assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient
to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall
execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations
specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not
so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required
to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall
surrender this Warrant to the Company within three (3) Trading Days of the date on which the Holder delivers an assignment form to the
Company assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for
the purchase of Warrant Shares without having a new Warrant issued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>New Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of
the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by
the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division
or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided
or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the initial issuance date of
this Warrant and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Warrant Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the
&ldquo;<U>Warrant Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the
registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder,
and for all other purposes, absent actual notice to the contrary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
5</U>. <U>Miscellaneous</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>No Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights,
dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly
set forth in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant
to Section 2(c) or to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event shall the Company be
required to net cash settle an exercise of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Loss, Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares,
and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant,
shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the
Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant
or stock certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Saturdays, Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required
or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business
Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Authorized Shares</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a
sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant.
The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with
the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all
such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any
applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants
that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise
of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly
issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof
(other than taxes in respect of any transfer occurring contemporaneously with such issue).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending
its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale
of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant,
but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary
or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the
foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise
immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company
may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially
reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof,
as may be, necessary to enable the Company to perform its obligations under this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Before
taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the
Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from
any public regulatory body or bodies having jurisdiction thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Jurisdiction</U>. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined
in accordance with the provisions of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)
<U>Restrictions</U>. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and
the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)
<U>Nonwaiver and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall
operate as a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision
of this Warrant or the Purchase Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant,
which results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover
any costs and expenses including, but not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred
by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h)
<U>Notices</U>. Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall
be delivered in accordance with the notice provisions of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i)
<U>Limitation of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant
to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of
the Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company
or by creditors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">j)
<U>Remedies</U>. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will
be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate
compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to
assert the defense in any action for specific performance that a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">k)
<U>Successors and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall
inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns
of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall
be enforceable by the Holder or holder of Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">l)
<U>Amendment</U>. This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and
the Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">m)
<U>Severability</U>. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid
under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall
be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining
provisions of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">n)
<U>Headings</U>. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed
a part of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">********************</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Signature
Page Follows)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above
indicated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>CYCLACEL
    PHARMACEUTICALS, inc.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Datuk
    Dr. Doris Wong</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTICE
OF EXERCISE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">To:</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">CYCLACEL
                                            PHARMACEUTICALS, inc.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only
if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
Payment shall take the form of (check applicable box):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;
] in lawful money of the United States; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;
] [if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection
2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure
set forth in subsection 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrant Shares shall be delivered to the following DWAC Account Number:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Investing Entity: _____________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
of Authorized Signatory of Investing Entity</I>: _________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Authorized Signatory: ___________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
of Authorized Signatory: ____________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
________________________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
B</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">ASSIGNMENT
FORM</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(To
assign the foregoing Warrant, execute this form and supply required information. Do not use this form to purchase shares.)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: justify"></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
                                            Print)</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone
    Number:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email
    Address:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
    _______________ __, __________</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Signature: _________________________</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Address: __________________________</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>form8-k_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 form8-k_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !W 2X# 2(  A$! Q$!_\0
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MP++$S+\R_(U:Z(B(JJNQ%^ZBT2W4%LJ^;*J;O[S4^&99DW+]RL#UD[DU%%%
MPKQ;]L+6)]"_9=^*%Y:-LN$T"Z563_:78W_H5>TUQ'Q4^']O\4/AOXH\)SSI
M!%K.G7%DTVS_ %3.FU7_ . T ?*'_!(SP]::5^R5%?0*OVO5-;NI9W_C^38B
M)_WRO_CU?<U?EM_P3:^/=I^S_KWB[X"?$NYB\-ZQ9ZM++8S:@WE1-+\J2Q;V
M_O;$=/[VZOTJU7Q;HV@Z-_:>I:O9:?I^W=]KN;E4B_[[:@#?K\A_V@9O%/\
MP3D_:GUWQ3X,T];GP?X\L9_LMEG9#%=-_!_O12[77_9>OU)\!_$#PY\2_#T.
MN>&-5M-:T>666);VT??$SJ^U]K?[U?"W_!8/_CP^"/\ V,DO_M*@#VS]@?\
M9UN_@A\)GUGQ0K7/Q&\92_VOKMU<?ZU6?YDB?_<W?-_M.]?-W[0,*>,_^"NW
MPLT74_WUA86UK+!"_P!S<L5Q<?\ H:K7Z;V_^J3_ ':_,_\ X*3^%-<^"W[0
M/PU_:)T&U::RTR>"TU'9_"\3OLW?[+Q.Z4 ?IM17F?PB^-?@GXZ^%;3Q!X3U
MFVU*TN(EE>))5^T1-_=E3[RLE7;GXQ>#+#QGIOA*3Q5I;^)=29UM=*2='N)=
MJ;G^1?N?\"H ^%?VD?\ E+/\$/\ KS@_]N*_2FOS/_:?O+:P_P""JWP7N;N>
M.VMXK&!VEN&V(O\ Q\?QU^A'_"Q_"?\ T-6C?^#&+_XN@#1U75[;P]I5[J=]
M*L-I90/<3RNWR*BKN9J_/W]@3P3!^TAXS^.7QK\66+7=KXMN;C0+!+A?^7!E
M_>HG_ /*3_@%>D?\%,/C+'X,_9EET'19TN=8\>3KHM@EN^[S;=O]:R[?X=NU
M/^VM>?\ @/\ X)=:OX?\$:3:0?'+QQX<E\A)9],TF7RK>"=DW2JB*_\ >H Y
MK_@F;X@G^"/QW^+'[/NN,Z-:WTM[IBO_ !>5\K_]]Q-$]'_!5+_BI/CW^S[X
M5OOGT>_U-?/A?[C;[J*)_P#QVO+?CU\$]5_8!^/OPJ^+:>+-;\>:?=:AY6IZ
MAJWSW&Q-BO%NW_-OB9]O^Y7OO_!5CX::GXX^%O@?XM>#I6N9?"LZW;RVWSNM
MK+L=+A?]QT3_ +[H _0*VMHK:)((E5(HEVJB?PU9KP']F']J7PC^TM\.M-U7
M3M5MH];^SK_:>DO.JW%K<?Q?)_<W_=:N_P#$WQB\$^!M1T^QU_Q9I.FZA?SK
M:6MI-=)YLLKMM5%3[U 'P;_P5\O)]-\0? ^\MK9K^[@U:XEBM%_Y:NKV^Q/^
M!5ZA9_MG?M 3744<O[+FNPQ,RHS_ &S[O_CE>>_\%9'V^.OV?69E14UUW9V;
M[O[VWK[\_P"%D>$?^AKT3_P8Q?\ Q= 'A'_!1M]_[$?Q09EV-]CM?E_[>[>K
MO_!.O_DRSX5?]@Z7_P!*):Q_^"@^JV>L?L/_ !-NK&\@O[5K.WVS6\JRHW^F
MV_\ $M,_8!\;>'-'_8]^&5K>>(=+L[N+3I=T5Q?1*Z_Z1+_#NH ^K**P-&\4
MZ-XAE>+3-6T_4GB7YTM+E9=O_?-;] !1110 4AZ4M(: /DS]KGPK=Z#>^'/B
M#I4;?:M.G2*Y=/[F[<F[_@6Y?^!U] >'-8TWXB^![?4(HT?3=4L_N?>^5E^9
M*M>)]!L/%ND3:-J"^=:7L4L4J?WE:OG+X*>)[[X*?$.]^&?BF7?:74OFZ5=O
M]Q]W\'_ O_0J]^FOKN"Y8?Q:/_DT?_M3XNJO[+S&4I?P*_Q?W9__ &R-SX-7
MD_P<\<ZG\,-:E_T2ZE^U:+=O]R5&^_%_O5JIYOP"\57'[J3_ (5OJD_F[T7=
M_9-PWW]__3)__':[KXN_"NQ^*V@)9SR-9ZA;MYMAJ"??MY?[U<9X)^*,Z:C_
M ,(/\2H([/Q$J;(KN5?]$U%?[Z-]W=_L5'MHXF,JT(\W-_$C_P"WQ_K3T8>Q
M^HRCAYRY8Q_AR_\ ;)?UJO-'6ZKX,2^U1/$7A6^BL-3G1/-E3][;WJ_PK+_\
M6GS5;N?%-TD4-GXB\-3_ #_+]HM(OM5N_P#[,O\ P-*Q8?A=J_@EO-\!:G'9
MVF[YM!U!7EM/^V4OWXO_ !Y?]BMC_A.-<TU&_M?PQJ$+M_'I[)=)_P"._/\
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MW8^[[WRUU]% 'QMXX_X)8_ _Q5K[ZOI]GK?A"[9][)X>OO(B_P" HZ/M_P"
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M\5>GRT\1+VM&7LZG\NT?E+IZ?B?/VQ."C["O#VU'^;>7SCU]5\T;UMX#\=>
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' %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>cycc-20250901.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWaOPGbP9z5Z8mekhvWB4bQla/yAkAKUwmSvgt0lWcVcP -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:srt-types="http://fasb.org/srt-types/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:CYCC="http://cyclacel.com/20250901" elementFormDefault="qualified" targetNamespace="http://cyclacel.com/20250901">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://cyclacel.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="cycc-20250901_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="cycc-20250901_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="cycc-20250901_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" />
    <import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" />
    <import namespace="http://fasb.org/us-types/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2024" schemaLocation="https://xbrl.sec.gov/country/2024/country-2024.xsd" />
    <import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd" />
    <import namespace="http://fasb.org/srt-types/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd" />
    <element id="CYCC_CommonStockParValue0.001PerShareMember" name="CommonStockParValue0.001PerShareMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="CYCC_PreferredStock0.001ParValueMember" name="PreferredStock0.001ParValueMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>7
<FILENAME>cycc-20250901_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="cycc-20250901.xsd#Cover" roleURI="http://cyclacel.com/role/Cover" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://cyclacel.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cycc-20250901.xsd#CYCC_CommonStockParValue0.001PerShareMember" xlink:label="loc_CYCCCommonStockParValue0.001PerShareMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_CYCCCommonStockParValue0.001PerShareMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="cycc-20250901.xsd#CYCC_PreferredStock0.001ParValueMember" xlink:label="loc_CYCCPreferredStock0.001ParValueMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_CYCCPreferredStock0.001ParValueMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement_40" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport_40" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport_40" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport_40" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport_40" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate_40" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate_40" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate_40" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus_40" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus_40" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate_40" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber_40" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName_40" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey_40" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber_40" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber_40" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode_40" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1_40" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2_40" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3_40" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown_40" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince_40" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry_40" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode_40" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion_40" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode_40" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber_40" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="loc_deiExtension_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension_40" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications_40" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial_40" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer_40" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer_40" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle_40" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag_40" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol_40" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName_40" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle_40" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation_40" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer_40" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers_40" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus_40" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent_40" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory_40" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness_40" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany_40" xlink:type="arc" order="49" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod_40" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard_40" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber_40" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany_40" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat_40" xlink:type="arc" order="54" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent_40" xlink:type="arc" order="55" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding_40" xlink:type="arc" order="56" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock_40" xlink:type="arc" order="57" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>cycc-20250901_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="cycc-20250901.xsd#CYCC_CommonStockParValue0.001PerShareMember" xlink:label="CYCC_CommonStockParValue0.001PerShareMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CYCC_CommonStockParValue0.001PerShareMember" xlink:to="CYCC_CommonStockParValue0.001PerShareMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CYCC_CommonStockParValue0.001PerShareMember_lbl" xml:lang="en-US">Common Stock, par value $0.001 per share</link:label>
      <link:loc xlink:type="locator" xlink:href="cycc-20250901.xsd#CYCC_PreferredStock0.001ParValueMember" xlink:label="CYCC_PreferredStock0.001ParValueMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CYCC_PreferredStock0.001ParValueMember" xlink:to="CYCC_PreferredStock0.001ParValueMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CYCC_PreferredStock0.001ParValueMember_lbl" xml:lang="en-US">Preferred Stock, $0.001 par value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>cycc-20250901_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="cycc-20250901.xsd#Cover" roleURI="http://cyclacel.com/role/Cover" />
    <link:presentationLink xlink:type="extended" xlink:role="http://cyclacel.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cycc-20250901.xsd#CYCC_CommonStockParValue0.001PerShareMember" xlink:label="loc_CYCCCommonStockParValue0.001PerShareMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_CYCCCommonStockParValue0.001PerShareMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cycc-20250901.xsd#CYCC_PreferredStock0.001ParValueMember" xlink:label="loc_CYCCPreferredStock0.001ParValueMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_CYCCPreferredStock0.001ParValueMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Sep. 01, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep.  01,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">0-50626<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Cyclacel
Pharmaceuticals, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001130166<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">91-1707622<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">Level
10, Tower 11<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Avenue 5, No. 8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine3', window );">Entity Address, Address Line Three</a></td>
<td class="text">Jalan
Kerinchi<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Kuala Lumpur<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">MY<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">59200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(908)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">517-7330<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=CYCC_CommonStockParValue0.001PerShareMember', window );">Common Stock, par value $0.001 per share</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value
    $0.001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CYCC<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=CYCC_PreferredStock0.001ParValueMember', window );">Preferred Stock, $0.001 par value</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Preferred Stock, $0.001
    par value<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CYCCP<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 3 such as an Office Park</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=CYCC_CommonStockParValue0.001PerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=CYCC_CommonStockParValue0.001PerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=CYCC_PreferredStock0.001ParValueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=CYCC_PreferredStock0.001ParValueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>2</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="form8-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyclacel.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>cycc-20250901.xsd</File>
    <File>cycc-20250901_def.xml</File>
    <File>cycc-20250901_lab.xml</File>
    <File>cycc-20250901_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="form8-k.htm">form8-k.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>form8-k_001.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="27">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "form8-k.htm": {
   "nsprefix": "CYCC",
   "nsuri": "http://cyclacel.com/20250901",
   "dts": {
    "schema": {
     "local": [
      "cycc-20250901.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "cycc-20250901_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "cycc-20250901_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cycc-20250901_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "form8-k.htm"
     ]
    }
   },
   "keyStandard": 24,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 2,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 3,
   "entityCount": 1,
   "segmentCount": 2,
   "elementCount": 65,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 27
   },
   "report": {
    "R1": {
     "role": "http://cyclacel.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2025-09-01",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-09-01",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8-k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "auth_ref": []
    },
    "CYCC_CommonStockParValue0.001PerShareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://cyclacel.com/20250901",
     "localname": "CommonStockParValue0.001PerShareMember",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, par value $0.001 per share"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CountryRegion",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Extension",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "CYCC_PreferredStock0.001ParValueMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://cyclacel.com/20250901",
     "localname": "PreferredStock0.001ParValueMember",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock, $0.001 par value"
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12gTitle",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementLineItems",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementTable",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0001641172-25-026110-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001641172-25-026110-xbrl.zip
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M_N2L F;&'U*:SL$#:OJYT5*Q!#;:K@-1N KR[7,*9B.T4"T18JM7"$N[ANK
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MNM)[J)?B8Y*2Q:/7OVZ6"7HB+(MI^F9P=' X0"2-Z"Q.%V\&'R?#\\GXZFJ
MLARG,YS0E+P9I'3PZR]__QOB?U[_8SA$ES%)9F?H'8V&5^F<_HQN\)*<H=](
M2AC.*?L9?<+)6FRAEW%"&!K3Y2HA.>$[U('/T$\'1U,T'/8H]A-)9Y1]_'!5
M%ON0YZOL;#1Z?GX^2.D3?J;L,3N(Z+)?@9,<Y^NL+.UP<UC\4>&ODSA]/!-_
M37%&$#]=:7:VR>(W W'<XK#/)P>4+4;'AX='H_^\OYY$#V2)AW$J3EM$!CI*
ME&*+.SH]/1W)O5K:4&ZF+-''.!EI.V7)?&_<HJ\XR>*S3-J[IA'.9:MW'@:!
M"O&_H98-Q:;AT?'PY.A@D\T&^N3+,\AH0CZ0.9+5/,NW*TY2%@L0!L6V!T;F
M=C,)8R,1/TK) N=D)@YT*@YT]),XT'?%YFL\)<D "27G ZS7::VL(FCDVNP=
M83&=7:0O<VU&>[+/OSLL_XH*5..=5^&>YCAYD?EJI'/;-^1E9WP7Y_Y,\VZ>
MO.Q,5R+_$MMYT_+>I]=^7A.Q\9I_JEDDFYP/8&2F38HB6GI@>00Y,!1EEZ73
MJ%9N(GISRIIU%R.C+'..LZDL>)T-%QBO^ &._S4B29[I+4.Q19Z$8L,7,3:2
M)4GS<8*S['8^R6GT>+Z),WT<6<DW@Q[ZD5D!$7G.="TPBSI.1:$8190/9*M\
MF*B3KL+GC"Y[V2C.&>TA_I),R_+52>86@(K49(QD=,TBLE<;5VO3]ZP6#I<)
MCQ#S-9(./TX&OT@9HG,DA>BSD/[O]6A7]$M8BK91) #Y\?#T4 [OWXW_'(^_
M\+G<DJ;R0'>8R3G4X0&?!O'^??* &7E/EE/"C(KM%>D"G!=412"T1YAWF/;W
MVL!*!BNH7J$59NA)%(#^*8M *SZSST0A?Q%I=WPG88S,I %ENZ@##%F/(&=\
M]:Y B59G1!A4];5I E7&::8T21JMKR7IVXU_]WBZFUA W7,A\C+2U0Q:AS>I
M\ Y,JRT3D%*$/DO95P]BWPX(/K$C5_QCYTRH(O0"1L.H%8Y2%1X@IK462(04
M2>VW)24CT<&"/HUF)%:0\ \[-OA_OKRCT5K2S$LT*M3<[8(#R)1H?7.?]S8'
M#)DMK25(:!PW\#D_\$P<_#+!"XM]8[^K)K;:TFU<VQE$(]L<F:U<:I 0^6KF
M=R2+6+P2-TC;ZE&3.6]TB\E&VU<T82'0- :34-%ZZM@_D$6<Y4S>,2]'G)9N
M#-"[[OI;;9MC@54<!#1]'(*C134(E5&>.#I/TS5./I 596WXU&6NJ;&9-&&I
M:H)BQ&(,1$-ID1)[(N+?:\QRPI)M)Q0-I6LN *LF&H8L*#KLWD! 2KE?1NX9
M3K-8=&"=D#2ESB\W +.-2P]#%Q0G@#GXDJ34^R5E\D"21#Q@@=/N#L4F=DT+
M;-CDI:D,BAC0'LB,C$!%2#C87#R)V3F?)O6L;$7O$YZ&[39^2G&P")D.>U(D
MPY"(\T12Y<&.#H8:2M?T %9-;@Q94,38O8&L*#F2>O^07*2S7HB4.C^ &#;M
M>!2B .&H.^M"@ZM]@G$99Q%.E)=+OLW\>:5#ZQH0T*X)24,8%"B0.Q 6%:"9
MD2%>@?F38-8/EXK2#RP-JW942EF H)C>NC 1>B^0C->,U5S#(PXL=85)EUG-
M":0+ I0.<XU'BI2\!HJG$>@BS>-\*Q8HW*PM3Q/9):[8@,QI)LS]0;  F#(9
M4#(D=$@)O;2\_I4@S<6R$+ ZILPM 7:3=0KJFH!(L!H#:-AIY2H=+T2,><_$
M<'*5SLCF=[(%Z]70N64"L%F'PA %1(7=&8!%(492C;C<"QAW+%YBMIW$4<=0
MT12Z10,R6F?#5 4$!V -H*-0H\G5V.=(<H\W5S,.:CR/U0J[#DI O5M8.FS7
MF0'$ :'3[A @B >A>I1/D*[2B+(5K3SN,*9KW@%NQW0&SU ZHMQ"U:L*=;1:
M0P("K(]/ +-:Z"OU3 JB8F&T+ ")$KP0=SZ;\1.5%?]<QRDY NMOU;JEJ\5N
MG2F+,""28'< /X7RE?Z 1 RZ34.!YGB/JA[[A^:X+S3'04-S_!)H[I]I(-"<
M[%'5$__0G/2%YB1H:$Y>! UO>*]]S9A_O&7W]-GV<#:H](),TZH5F)TL/%P:
MWKI@$0%B/B-"?&(B)U:W[([1ISB-X"DS)/<"#&#:2HVA#0\=N\$N?LH)L8[S
MVM>H27GGET3+_/0R=9/V+D9IPH.D;JRS<U%JGTC<T2S'R7_C5>N%N%WL!0^K
M82LD-65XJ-CL=0&C8A /\G%A7> J?M"P+B4S]CO[M=EFJ_R)N;HS" ALCIKY
M*=3=$R5RW<R"448PT"/4=SMK9(NILHTK^\)HXJ:A1@O+[S77^/@BBWQYR=T#
M3>$'!)H25RT-F=.M;>X/HL4!4V:K2QF2.D]WXT7.KLS>?5?V.1O933OE0*YW
M!-&ZIIO&,*WW.V[-/UB<\R.+;$;KM/B5Q_;<(*!SU<JM-G6+6T5!M'Z;,Y.$
M0HOJ8L=83&@21W$>IXOW_.*3Q=A6*YO(%1"P04U#4Q$$"J"M1B:74HBTTC$$
M=XP(" EO"+D(4*1J9+?SN76T;Q.[@J+;L(8#5@8!2:<]2_*P852)0"H$R1B_
MV%QEV9JPO>"QA'A""#0/@-30AX@39+(3*A7HDZT)B=9\?-P>'4_OX[R1A,XN
M<38F >;*$<G8'P0;@"F3!;E/9%$].OY^^@/248Z;_X;>,RRR\4^VRRE-@.Q3
M5I4K"%HL:@XLDB!0@'V9--Q05$B1TOK(3E4S:ZF.L=\5 %9;NNEK.X-H=)NC
MQI>_UM:>NOR+3?3 31%@08)=YKKKMYDTN_^J)@@$6HPU+DH**=):'PL2=D/6
MHGL2L/ V"5AT3 (6(4X"%GTG 0MODP!]6)4BA/=+M],D7F @.6&KVC44+99-
M/BS2H%"!_8%]1AF"=C&N,UK*%&?BA4=L*8]_R3]8:@GHG.6T;+-9)K6TB8)@
MI,U9(ZVE2CI7$2.A=LW%>A;G9*;,7,8I3J,8)V5Z1-L=\>X09[3T-%^"TZ$/
M@Z%^)ALXJ3"=R[ ,W*6Z='TK73V \0=)DM]3^IQ.",YH2F;J7HKMEZ)VO=LG
M9CILUQ^: <1!X-3'(?#HC @:/HHHI,.*.V%>2/I$DW6:8R;7DC-;SP3HW)(#
MV*P38X@"(L7N#""D%".E]K- 6V6/*"=9ZDV.8 4AN>/EVJVFC57;5FU S+0:
MA-9P%SD_=G-C%>5IB65.&([R^(F\PSDNO('UA>2N%U6VF3974]JT 2'4:A!<
M/UG&B%0Q6#/E+64,&_.IUH*V/"5NJ-PGCFE8;.:.*24!X6'SU9)!AB&M]<+"
M9(F3Y.TZBU.2P0.1H7++@M5BG86:)" 6;+X %J04::T7%BZ6A"WX\/8;H\_Y
M0Y&?%:P;H';+1JOE.B-6:4"LM/D#F-$A2,7HE+I^X-GL$HJK+(MP32U2Q]B
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MDIS>T7&0RCR)EW/3DS2S':&5[YLJ.CYKA<LP-!4=ONP>=]-J?NU+TS];@:W
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M:)I\,$?S(_:7_>\*S)Y_ %!+ P04    " !,,");LQ>YR&4[  "%F@$ "@
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MT5B?AWGY-3I+? <">@[L T7$$6P,LD3-T/S!YTQ3?W#XZ."QJ5A9:=/??_0
M']T:?]N#=9T5][6W8M<F\*7<-4^#033\."YRX+_HL\Z+)^@@J]2]Y^=P?^NQ
MRH+O*=MPI&>UW I.2T!7'5I?3C@V\*.Q;7=9JY&/0(WL_5TG0WF)I4?#*FSS
M,;(;KXH^FGBS]F_"=(?P3#1$7R=LZK"LN2DQX0*51>-Y]*/>-&6RNS';@(?
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M2,!D]@=+E$(7B&RO&^[&L@13YY7M.PMG^BKQ,"O>Y(X@T/XE<811+92-5T3
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M($.@L?3>\Z,+-%=>G[V!PWGQ]OWK&Q8WR-/X:UWAW9S/>@;6PPU;6%AD?\D
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ME8K6=_+KR:NCD[-7W<Z[ET?O7\-?/UR>GQR]N@B#)!L>[.["EQ_LY='QJ[,
M]N35NZ/3T_,W__V/>X?WZ-\7[XY.]+__X![<K_(9[</3X#J)JPG^]O"O,*/+
M]_J55ZJHDF&4ZIV!7RRA=)SLJ?Z9O.[QX5_]IU,UVBA3_CDJ8$^KX&(2%:I\
M$CQ\\/?P\/#0[.+EZ7-G5BWS-BM_3 O?V,3.LZ1*HE24E37_G'T"FDA*%9Q&
M%;SI?^:9"AX>AO"_AX_=):&R<_E^ \>TL:-I:"DW;OR?&.J\+.?J=CO+&WJA
M9I6:#E01/&AN*FVI5BZ_IWNW91+B3A7%1P>/DVS9$CZ+,)4/DRQ6]/(DV^3F
M7;X\!P6"%8G@!CTBZ%43%7R7QK_/\Z?//F@N].S[#\^_*^C#/H@0N)&C!.90
M3:(JA &+X"I*YRHHU% E5RH.@W^[?P)X(*G*("I+6'79[=0&>9FGL2J\,9(R
M@*U(JA1?-I_E68 _ <DUA==D<5#.![^I807<@+Y(DVE215629V4 SRK-;?!1
M_'Z89W'"7T]4H9(L&L&[NIU253C]:A(&405/+X(*]A)? 5.F9^CG,=PQ^F$^
MJF^0<$.?P7E+P3GP"V=% O\/4W[\Y/ PF!U,#X(>'&.W\VM>? Q.DHJ'[^/C
M#H=\=%@?]!+V =: "VJ.-YA70997./%"T1I"'!-VK!P6R4#1>>&D9O-B. $Y
M'8R*?!J<+(9I-%3 U]^!Q)G"7^?$=X&PSD%#@0T*3E4:78,T@NTL9GG!X]>F
M=I)/9["/[HSP '$&(L&"DB1:T(M*]QBC&"_#%$Z==GH.=Z$(NYU6<A2AZ"T;
MC@;&GL*,+JI\^/$@N(1?FB7"U@\5/I/#MM($ZC\(:$38-2 ]/0P\F*;! #BR
M^GT.ARS49L[Z';X5=J8,8C5*,A6#,@?7<$@;\[ WZ!]\5IW\;MG(YS36VQ=T
MB(QZHX;'A^=R6MW. Z2F@P ^.L6S9&[!GYU$,^ N*?PP%A8T+^&O>(?PHN5X
MTZZ1'C05,(\1\IE$5XK(9JJB+,G&0/6:ZR"Y( \EEAHE, N8SKR L6$9[S3M
M'HT+I>ABU.Y:\PG_VB';BGU="X@5*'Y,\Y&K:IBDOBP%<&ADU%&5%PMF(U7^
M12EYXP>_X[3\T-"R9E7TP4ZM]VZ/<*E*>-?+BOJP"GMN**4<'>P@<+]P+RU[
M!4M0P68@&='(CX/!PA=GTV@!P@S^$RMT.P37DSQ5I)QEP2PJ*D\)ZG905Z'9
MU]6A5IW'T7,&"K@;\[RZIH)SBE4*2B*REMSC0["B*(CGZ0+UM^$<5_#N]$6W
M,\QG"]040,635:G[TRA)@QZ,)7^-JBH:3I %]O7.O,DKD?EFG@FKD>BG@.EF
M, SS:IA(C;4V?^RRUH-NY^<$MI9?IZ(B36!K4#E,^J1A]![T@\LBBH'=P[*9
MQ?82^!*?S^9DJ,'CSB,E*%53T%+*1+CS104_BHH8**4"-9CX_SL@FCPFS4E$
M3;?C:1QQ'V? XJ</ZTS3_%J_D)18&-0JQZ!*XT&540)*-C["BKC(+3DF^B(:
M@X09XPM\W8=T27@ ! 8K=>5,#=$VB/5>1[-9"FKD(&T]$#C+ZP1)A=Q'N"E%
M,(S*"6SG=T6)>PW[,E&@G<5%=)TA?47!!R _&  VJ((1!U&&NENJRI*U1?P]
M_LLN=%;D0Q7/81QO>G;;AJ U*]@J-#MNMX(#^ P>_'@_A_L'A)[*,W![G&5J
M/1)NY^]S6"]L=Y;K?4;2GZH8_HJ3&<\CO*M*$763:A%4BQD-:K^#KT#SB(KD
M/W2UB.;Q/<T)=CO.L#C;ZAHHMT3B0L* 'R$=C[7*(E<2["4XDF+10A:H\3BO
MQ%_,)HL23844KVE1J*8B7>5\-OJJS\&V2]UW PLSK PT*QA';K&O\0?1%=QV
M.@MC)!C]13^*[QHH9<U .LK1/$U#NB[7DV0X03)1+<M;N@"/58V(3C,PEU+F
M;=>:'11X<H_Z_M66M? -E GPAHP<FO%95:DO(.^Q,_I!\ Z8-3)@O4 9P9DO
M[-4\K7 "R-ME8TMFL6"ZT9QY5C /H*34X4IK;'E-LU6C$5IQ\%NX1,"CA./D
M\\H0VM+7R^1P@&['C@#3CC)45H%4 L_Z<N[C32]%BK^T)ZP)19\BKP+D1X;*
M-WHO\B)&Y7=BN>;-0YC7:@9;SH&\S)[S#/PA-6LEJ4<6,)X'&L'F#OL,1/P?
MKDB!K\G=,JO,F!G]$O2^X^>U59.:3]X7!40/7#<:#M6L0@JNDPXH <./67Z=
MJG@,LZ!?HWDASA[X;:&BTI /,M<KD%KD>9$W@2X!/XEFD[ F@HRRTD*']?VU
M3@"FTC7H$V^E&<+A#ZS4C&'+,_;OB")$4@*6)7R>::VLR&J2'1]%0^WYN=,@
MS1?3-W=4C1[4U&C25EB#QJOAJ ;(>&?,TF[G%,)K]A>DB1\/#L&ZOL&5U7!Z
M-J=FM,N=.XU6(H.%_9_[]X,7B4KC)R#2QNHIO.#WN0*F!#]\&KR=D0_F"0XD
MNMK3X"=T-,/7P?W[$M)X=GK^DYZE!/\&>57ETR?!WS#^-P"FK@KSV7$*_"UX
M /M1YFD28TCP-H%(>=L0^%HT*V$F^F]>H+'-/K]%2$L"5NU1)H[@UN.:SE;J
M37P:7(+B^"0X*J)!,GP:O(FFBC<:=%;8O@?NC[[7O\)O;-1(AXN>?0^[W++A
M Q &'^^SP?<$&#\>HAN!_1LO_>O?86\W-;VNW 5W\W!3F2+OS*VRZ?CRCC+^
M(3/^$VT$>@ZPX'R$V@"%DBC.XUC#$MXA=R=JWUDN:BVH#:#RC).RDH@':0C$
MW?EC4GC#@"UAU(?0A*SF)7HN2+-4,;\6=$QZ<5736?!G25G.K3K6T(9$]V65
MCC2BK.G;B=(R1\%D[![T\G0[K6X>4AAI$P8+\DR+<2 "JF%$BW *C/W4L)QP
M8 G9X70E%@BO9,V-%-K:JCR]'EY?);BK^4 V#7U%R55"*N\_>T?WC_M![Y?^
MO_#SWE$_A(G IC[9.1)NOYG;G2[SH+Z7PLYJV13R].'!PS^SI_>> WGX626<
M5]L<Y\&?&^<?GR$KI,U)7*Z7(V)-Y2?DFL1K]M//1^_:[,ED.E5Q IPM70 /
M@\L;UQV'K<ZP]2;B>3;$6FUW>J#GU#H^P)I#MDA:M77717W-K<D?&$>+]69!
MH3;-@7UCN@AZ#V\]L/L&BNVO.0WF=_E,83@0-T"8+HB3>1H5Z VE]TYRF(5F
MO#T_ROQ^#D?PM\/#WH"<?^_IIS3--Z\OUIL'2*KI/!V3N:OM'!!("OX&7+FT
MD<@TNBXI*8'.S5EU:)W:DV0\4645'">QN(;ST;JGHGR;2X@3=C0;)C.8BA[Q
M=51\5!7ZK0N%S@,6$<=IGJ. &0>O#MX=!#UK8IEO7.MJO4EI?]YU3H1!)Z'O
M@%8=K 0TOFH3VE@>@]"4M3:MM)'?ZCMDR3B>DS-N%7V%LC%K7N2B?6ML<&B8
MYNS@68>H&]=HW3L$=-?"SU9RJCH3:KCLVISGZ\P%=CQJ1'O6.IZ;N(SLZG6^
MYJ:8X_#=;K<]DOHU?[J5&9J;?)U1(+8BB[1E*#<#=(=/KG?<KO=]W1K>O>?-
MK+*&6[[. C!Z2WY&B6&3!'^*O.>;//A?MO'@6U1[+^94/_.Z4P#UV>M\GL9H
M?),' <4=I<LJ+T_$<11@8&V(@2[R-J P=U)K&P^S:*S/P[S\&ITEO@,!/0?V
M@2+B"#8&6:)F:/[@<Z:I/SA\=/#85*RLM.GO/WJ CVZ-O^W!NLZ*^]I;L6L3
M^%+NFJ?!(!I^'!<Y\%_T6>?%$W205>K>\W.XO_589<'WE&TXTK-:;@6G):"K
M#JTO)QP;^-'8MKNLU<A'H$;V?M3)4%YBZ=&P"MM\C.S&JZ*/)MZL_9LPW2$\
M$PW1UPF;.BQK;DI,N$!ET7@>_:@W39GL;LPVX"'P\UE>4IZMR3=AVQ@8D)N;
M\XW$PW9@6=;R3N)NIQ[89"D12OW!@HRO4)OZ0\R>KBA;4&<N8G9,45::U*Q-
M,TRC>:GE']EY6""'=I.8=:X[H=M)2O:7IPDI2S ZNIHYQA_5G L\GT$2VXJ!
MAG]"N^S)#P!7\/>Y*KD40K[(%-ZGRG&CX5+[W4[-[2;^C-QUJ7LC+9WY4A=(
M;T I*0V[FDH\?GSRZ#"(#J8'W0[6G03ULA.X?#\\.7QH*U/J3_3# /U-L,MO
M+T_^WS%."/_R2].IYN[F59[.IZ@K8(8J3AZT3XR7T0Y36*!UBXD[DH%^P[[B
M:FOS0>78V/\PZ6$K:>AIXQYW.XU-IG.6];0, :P8WDF+* U->*^/. DVLV<%
M7R%??)=D'X.W,_A&2 !7& 5E O<NPDA),8XRR>VCU-NQRH:87#<<*O'+YE11
M-9IGPTKGWO H^"U/JL_;/\W+BJ(QP.DM87LI#XV9E[F9<TB)P+VX3](&$_-(
MH\/TN3*4')FD0$Z$"^$Z,%($VQ,JR(OIWG-0#)$AS11Q)3RV(@() K-3*0@!
MEI3C/ >& @.!A!/>\,Y4*_!PT^BWO$!*Q2@;1LB591V.\*/S<!/3\!PYHPEH
MQ21&H1[M9]W)6D&.<5*4^@13EIPZOKXF##:+$L/"=,[>[C'[79=AZ%ATI%>W
M\T7$5TT&T&6\27S%$2Q]-=M=*MC6YKJ[),UPJLS>?P*JPD1QS9<M.=#W?L5A
M87[X2W ,6]3MM/_LEWIIZQ^4E>L=&B<6WZ6L;)Y@FZ@D4OUSLK)JE95. 1Q^
MQQ_[)P/2+6)JXMV :<AS4L[J2]S@[@5NM[.^Q WN3.!V.[>1N,%="=QNYW82
M-]@+W#^41/EPGR^YP7S)A_M\R7V^Y*YQE9CS)5\KX.V9./8^2]'P+1S&?RH9
M[*MUQ6_\*),#.LI3)P>EYN']@)$A/R.V69PT1.NDS3]L*YYL;4U%":=4OFG*
M<UGENM0EG4=C90OH)&,49/6P4 C)(BD*Z,;&ZIOVM!K!CXD55S"9SP=12IYO
M_6OR@..*3A6YEO,")G-9P/:;-5:3(I^/)_0^>0I?C^6\6&(:82EQ< *_R.,$
M%*5R 9KNU-4Y3W\^.O'U^9&K=Q@K)V('/F8P8;*/=O?+"TFA24BQZQWU;=8Q
M#'ECUO$,E;G*;-W-F<.P/JSR3:VSK?8,'(<<#&J>Q_U:$+#AW0^NDM:P!96
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M,P5J;N<ZJVTZ&$L<3R,5^$0;&SI9SCIVSES852NHQ0S"7YM,E18CZ+R6]N;
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MP"?!JZBL]IFT7U4.Z1TC@NYNR='WQV]/?R7,K9>7KU\]__]02P,$%     @
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MHQS-TS2DZW(]2883)!/5LKRE"_!8U8CH- -S*67>=JW908$G]ZCO7VU9"]]
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MT_.?]"PE^C?(JRJ?/@G^B@'  7!U59C/CE-@<,$#V(\R3Y,88X*WB43*VX;
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M<BY^7A).*:L@1KXCGY3Z9P<!U&=B]'I&?39S;\<ZYB?U,Z)8):*;X[3J> '
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MB^SB/$W(;QRS27HQ2Y/VY F_7S0P\E0%]9H9)]>6T;=GF-D>L81@8'N5Q5[
MM-N91I_0.H2ORZI(!G,=4W7_31T9;=P%I8Z?D5TXSFGQ->?F;TYPR8%XU@[X
M)%OJ_NV1O!+\BZL\B;65'^?S014Z_>'8L<TN\B611;%Z?>N^';G0@*CU!6ZZ
MG ]X][P]7CI21JGY*?H]BD;@*A0D83"-!TF&T4(G=HH12>FT!>H@'@^?78ET
MT;_%X.44<R7;1L=ZJ^2JS_M1<GNM88J]NB@35%R;]NT4U/+SFKU-'G*O8B&R
M>E2$XM(8@(AT.+#%D6@=1\;G2#@]GK/5Z6$'BT*TA=PIJEDG1!CTU&>]TQ4F
M_L^+A=D6'9]VM]@%J)>L!W;6HOK$?B'K5J)BI"RGYJ.WGMFR49WD"1HT-$X0
M![%3WKDF&J=U=A6Y1(1E+(WMRHTZ=*A\:0%/[<7:!\*)_\$\P_+>,>+R'64+
MUSU-WD%?J73@]Q!%T,R1JI]L=6)S9SC[F>JA*+EDI,%(- "%)6BK)9>M74,X
M0\7AD1Y#)!_@+6;5[=@':&:-$B?A*27Y\YD9&#"00MWWK^17U]7VLOU6;> N
MYH.2?!.5Y$,&;X$<T/M6+DT;LU>D-;61;P8E:#&W<M0!5Z*-J>8 &X\R@\\)
M924MZ6F/Z9P9N<PF(T_4C4_1I0E!)G$A0^C*;^.C1SX"VBCY,A%]-]*&(E_,
M;D??.G%P$F6OXM+XVY:>\S:QM"7MR<W@K$7;HB%[B+L=$^EC$];!Z]?1K]I@
M88T#UKYN!OZ&-OU$AHUUGI_I.XL[HM)X/<' ;[%LG3)6@+<MY^\]'7C!.1>Q
MIBX;YB=ESMK[;,CWVX1=-:FUD 6V)=P6RX9!<<Q,/M>8G04V%E-P=HF.R31V
M-N<4R"P7O.?:BT,[>E3Z8E:>=,AJV>:9D(>#E-8R83-;4D&]Z>X9[Y8L2[JP
MO0,>]!YYT*EKOC#//>76)+8/6;UFT3>A&AFZNI4N,+""2&:J484=M0%(B+BB
M;TZQS01\3\%_>AZS%3[A/$! <C=2=^A9"]6\R!QMW(90*?^@UTS\";R\'UJ#
M/V$N_2VU?<>KLOP_M'P?O^7&F<Z4(K,IP'C+68+O'(4-6R-TZM]!)<=S&%/Q
M)@P]G"@.1#H?.U.1<)63"MSW\V1=$O#$!B5/&N%I-4D?U\+U@:*<"8T=0Q2T
MI)UW/=5#E\^R"DB_=.?%Z-28&(I!5[@A)GS;2"<AJ>*\SVGQ5Y<PP>\1,"(?
M-RUA@K4$C.;O44,06+A!=]_J\J,NES8@/H!*5LD/>Q*24=.8XT%PF4MBD7NL
M-2B&C-K;*Z[R3"+L:8^]WN44,(/2UH+6:C1;=H7S-OU$7_<)2Z5$(A@>&*@%
M$;U>V$!E:I34@'& .*@:W:.STBE3_1+ED]^8T%P=]WV\C_MN,.[[>!_WW<=]
M=XVK"!+>BWD61U/.+KJTVHR. MS2\Q^:OIO&"<NY92Q8,!^>_T7Z#,+EH-(Z
MS0GN*F6]PDZB%$<7NP^FBES:))\R8DF1*VALD+J:\%BD&K"^]@Z$+4HH \1C
MH)HX>( NDP3T@P)3[I;-V)T,&FPAD!KI86#(8RX?IH'I!+/0I'"ADIE=B9@S
M"B0HO*8;""J95)B#;CG<29;$ AW@:>]FT]"'!P>K!)BWN77:T^^<@;N>T*FO
M&-$L*PW3,.)-5I_9AXIF*7[4NYXHFGHMB.$D?/$N$^2S5B'\['C6@QSEIV$Q
M"]@;ZZ_H.M(3(Z-"SPDGD.C,?=(=FA8")2;GCH<(O:@&?HI1>&U(QIG3&#AU
MI5,2'Q_^61.8!R93CT M^]%5SH#)^;6MS!OR;W6HJA:TH/C(FC<(0<G9&%SK
M!C7M'U".:U#0\ Q;<>:S-A DOC5XR/.T)-A!3D8W!]0\]<9+DM+ZL:D<*D-A
M1+FA#.*G7Q:O><+2NF'][0MNW#WD-//I%+ZPH<Q<XUJ;&T2@1IZ!V.T,YB4&
MV$K/NWZC*5P[D+!Q'*!D@SE[G\Q9RQ!;K=4^#8&1(O=V,K'F\QD^S1^5W%E\
ML& %OOUI\124ZUR/I3;-!B]*T"-KV#6Y5X@RWVFKO;'$R*VS?)G-V6)HM]7I
M4R3'@2#SZY/;"@3936[]JWZQHM^A.LE-86(^'%+VLY-TOF3I!EBGK5#3F-)H
M];;;TGA';)4VP^F[Q2KUG1)$^)LCCCP/PILORYQHF F,F*N;(YP7#0Z9H$C4
MV)'EO+CBZD'G5QRIY+@&QSFBE.YR@LV>^2KZCOZC%(@28Y$PC/.8WTF9SYC.
MBQ*^86GSM+KI$#B:;"$4U]HA6^]:T[:,1<[Y"VTTLG(R-_I/UCUSFZ? M:@&
M0%(B+2V518VXZ*IP/.+TY["F6GP8YSN;I0N]T&YGR=$%'IZ?+8A<]KBYBGZ-
M!XJ(]DX#VNOB[#2B[[J7KU8SP&N#Z8N+I&7Y,$_!JUHZSXPH3_H)*)U=6:@1
M%6CQKY%6L3\Z,!K;,8'\K*C+(;-#V0UKRRPDUI(!*1=HE<HVAE&8EPXG.:U!
MUPF 5K!*(6/OEH'5I(4M963U8)NA$Q[>>#'K<[#+0J7-V\A*CUT&1APL]3M:
MW,U5UVLYP+1<">9W<(G13;M8N>8@J;66T7C+TI=$6!^J/#XONS!L]8Q&\>";
M\?X I5,KMVX'ZY6I))PM#1(53KEY3>0*!K:[+9K$66EP9W^:#^<<3UX/#:26
MB!'W?1U2"JN-JD6O'5$5#U5(D>$T5&YO*X.6D1<U>%$6#\A@KNJ%/MV.X9#S
MS+EF,=RG17]-)FL2-E8*X&4X=NCI-\87.T;='=<ZL-&(ZN=MJL$ED4GO'<(Q
M%'0FOJ%IHAGM.\K0,5X%%A)E8ARPM#^4)H<R&'EGSFI@FY1K9&S11C:6T!-H
MZUE$W(JO"XA@)YU/QRYNC%USRS,CNE=G**T57^ TGZ5:T'I4PO)!XR*8ES$B
M@@0DN%N6+W_Y 5-L3T$<QEI?LLF] 2RGBCY1?A=Y100_G@,2=3FQ8E,;X.#+
M9)_A"^:MJV8HD8.;R26J V')9C!>N\00NAU11?#W<,4K*Q8#!4I@/DV&[FI=
M]6J9RFWL0)W0M>)<^R'W_#'79!E+6G;='%X@:-]-K=]H6*L$IKU6W8[<*ZM>
MQ3%K4SHE10L0 YS (+<M/+]7YFS.4%\R8J4FBNG.LJAOFP ++9TR6W18'$ME
M?49 -,YI':D#"I$J"H%7=@2DOSZ;.#@BS@LZ9D3;0G.IR3\];(-;(4" _QEI
M/+_F<-U2_EV):T)NVP^;[S''<YL764EJ+",LYS57@S>1#53\H6=:ZR4)E7-9
M*6>5KK]"K="R/K&>#N$-N$2C8/:ZZG#-TCERS2C'"'G</+!V^7*;C0Z['0QK
MD]\0RY-CSMVPPW DG,T@,C9:TL5OBM4[P4^S9U9#LD:7IR&QC"*L^IP1Z+63
MUIM>5+HUQ]$<!%R1_$?%JXS/>DI"O8^$@+&00UT/NER5);90^CSU/$M0_[ 6
M$"*W[:.W\,._[J.W&XS>_G4?O=U';W>-JWR+)97[;-'UEC7:G]W6+FO,9W<2
MI<-Y&CGYO4?DZ;.?NJJMT=EJ*$4&MXI[%P\E@NA^]N '8-751*IV4/<*1?OL
M=JB<AQ%\FBYX?^ UXS("B^DA]5"AF=O/5OKALM^5FWEY]68(<;-NF&.=HKCV
M>>QOS)8L:](78#U"%@+28BMHS_6V")="$$)LO3^>HQ^Y8B[X<0(F[)78G[70
M%G9TTE$\'^2[S=538UUUK*L"_ETY()Z-?IM8")HBQAC3'39F$A^A> [J@3=;
M[.J4B^HP,D=ZB?V9+TWV_%+08O8BN -'P:! Q%+;W5(X)?H$-4R7"3+9L?90
M)UNR+ VF8]G=$<8-O09Y#@/$V*HT1%U2Z6-+68*>AW3@E<Q0J!!(ZHKA#:=]
M$Z3PJW:XV>GRL0AW-T)8@ZS *!-#MF'@UE8999Q^6*@8X9^7I(C!4"=]5E-J
MT6_M?:*?4!V<^&@IK\;&F1OY8KJ!4V%*0CD,,4#@U0%'H/+"R<IRD0)06ZH%
MGIQRT$+_NY#ZP-ZI8+Y3C#!*C<O=+>2N>3:;8-(>=+O)QFK'/&AN(&?8>9FN
MA<[YJF?5<4:4I@].&34YK8DJ^[:?WH+>#(R4"B0=\,LE::C:KVNS4,-F_E]0
M2__3"65M27]^HI\N65N9V$>X$6=MI.N3TU6>SK,*V^51KI_])UP6V$<I4]'M
M)&5+KQ/)Z>2<.#KVT2A*&B=<K\2R15AM 7]=NZ,;)1J95(M$,[HNT$/%WP.)
M2(==]&=7-FD$+ (+%ZPES7O=)+@^543@5OC2AX=HERCL3PC:^J+FA'7*D'5K
MU\*F978[5,3$_FV1D+KM;^@(5XR,8@N$SWQ$*\IVN7^V5[SK1.L\&(308W$A
MIK1HCA.V, ,B$K09G.$H4\(.N:(N:Q7CR4W;6R37FM]^Q93+,%@]Y?8:8:3U
M1=M&ZE(S/X<7T^4<)J'30D-)4;?7NZA?4HK@SQCXE691PY;  !X"O=F 56/K
M. ]/OT7:(*RWEZU1D/8$[[8746%>"\^0]%N39"07L)9DV58)^KLV\6FM 3'K
M<AIJWK0OE@"WH*LR]XP51:TJJ:/,3>MLVU::JQ<=J*%HI'^#$6S@[C8+Q):R
M2LS%Z6E 5&L;=ALX8)I/:Z4@3E"F:Q9(TW,[.,*6P='-*T'V@7\C+%B)<4B@
M9I >(2H2]V?S ? 8^#DA^7/A*4>N=%B^5HUA\EJL &OCLV6"D#U1IO)Y"7)J
MA+4I[CZ[\5'I!>,;'J";4+ :V2CFY%$[)HS(_^W^_[8T?!!P&9]>=7-T=V-B
MKO4FYL8]PS&367I1YGXO5LYAS(RZ2 ?AH[?(=@BZ,K"1L;(V@OP2N]7,*@WI
M[(._<P-:S#Y0E=@A$K'<.?7[=P3;_FL?;-M@L.V_]L&V?;!MU[QZ";LP?S+F
MA.,(.UYHJ<0&_87M+T_I=?-4'$$@\4QL0#BZW]/;%W'(QMW22Y8I;--3NE8]
M)PHD_5S:&Z&9$@Q%M-7\7!KOB?/A<6(:<UY$%;Z7!N18@).&KQ-E!WF$R$J8
MVT+%5'G#4MH[=K< X-3%=OW18+M>.NX (:T]MNN6$*E@N^HC! F=2OH_:K.U
M_$G2:-DD-;G$:V'U%.1RD"(*?D.?+5DS;HJ 9^23S-G)9/K(W] 47BPHX#<9
MHIN@XVEDX!X].P&=)K'"<FNJVHS&7'2=CSD5C=.J=>I[MV,KLQMC^MXNL<%&
MM^T/(E.B>9 = YIAD2E.)1S-$6/7YN!1Z(#Z==1Z?3C0M,;5,^7,;>T>T8]+
M:C#G59L-I59QR<@8?QJ4A7N0M%A15$^&"W*;#J)KQVEFGYM>M&5;GQG>6\6&
MK?R]Y)XHQKLD'5FU@2M0I1KMU_EWB8!-=4/5J5Q +Z5396^A,:4'9NY,*:\O
M1 HCC''F0M4X% $V%<PBUXN)M0.D 61JPE #!-<$13=-$7/T35XA_=F0>;:@
MSGMB=CE)Y7"8Q:(E.91Q>9P&M4@ODT6)^B<:<N:\O4GYK>^">4:9H<[+,1-4
M+ZJ6^9X!D6*]BM<^LSDSI_/.RK%Q_73:V-"O]ZAO=)U3=$$*X?CN+6<H(<.2
M&H79FTN74I>6F1Q?^IZ/M+D@-N--(6\R$J=RNK ;X=<GX1GA[$/=',G"#%$U
M#=+3Q#228H7,P5)H]-T5+FIZ;[KTR*D->VUI2Y8E^*IO[ F6+<+5]-1BKQGC
M:0W(M<O8)"2@#$,E/B\] YDCBM=/0R"C&5QB;S C"TUD3Z(2[4+/>.>)G2XT
MTY/>7\3L';9K+[Y#H,W&72!/^-(,%FZ#YJ7BSS.("!0DL56 .L;_8R_JAU*R
MZ4E$GI!L*,5SKARIH!&,"5? @5EH\Q7>6L@93[0.4[0])[Y[/FEG&@VF0LOU
M?*Z8+V;'XQ0G%/BR]-(%P'"ZO<4:>P\&X/1YDZ0OOL):L9Z+'1U0&S&4(=HW
MZCQH/8@WI3682FGK3)6V9#MWXW>4D0E>:3V(V.SXHQW?$F3T43&D(S'W^N&K
M@ YRVQ[=O89\C8"GZ7!?CZ2XK5INFXR%[6A1.R6.I%4;9II4DL:PU-SHUU\/
MLA)T;+!"AU DK$SH%2KSOH9EPHI4-* X,DSB.G-&;88RO6)R>4P'?MS,#2\:
M+/T>R2.#47?BZCJK,\3!*2EI6,TI1\.-&6AE<G\'M\#_X+I>'AO7R^ND1 N"
M UI[I\N6D&>D\ULU+CMPB@NG*]H'@B[57MBGV#[Z0E55JG2[Y).HG+2HD7&N
M.(%!XHVN?21ZDF F2=(2 M?I=CX&+ZLP<XJ\7FWM59DZ#NRS+2P?-)%##QTF
M[O<28,Y6=3"Q1H3^:/G)HX/@H^M6$NO8Y$:,3"-ZMSM&3?_ \G)=S8MA?[)R
M]:1UW;+63<ATMC,>]H/<>S?E#8A[I+WU@2R36R1YGUWUQ:(G^93E$J)EH>EN
M[T"97K$4-LY@;VC@DBC!J_^O"9[OA)^OCM'^;1^CW6",]F_[&.T^1KMK7$5\
M,Z_R$OO'3V#3PN!4H=MXJ-W,KT'C3DW"K1O<\FR$80Y<G,U[M%>TE:,26%\=
M^W1DL'8<E _,K?61ARR@>4KSJWA^L3^_J3<_S_H0RX%SEX=(Y)2YIN%;+,A%
MK?L\VQ.8ARS>26=\]KR;&824Y O',\T$(,'@#*W 5$HJTRBOUF3*F4VHRS;<
M;GGL@"\KI_OX(,]B@<>HQ8GP(W&PFPTB=XJS08W-(7>O;"IZKCRW,37KD1X:
M*UQ"S1W'34P^81">X@M9+#X93HN4[@QVIK0O::+F]2F3NZCQ^N]$W&__LL2%
M<A%5\P+3JN%)Q+[ O[RD/%+\FZJ&7CM-RO)&JIG-$&A$(>TLC/>@,H$^BFL8
MOL Z^2PI#.D;E=F)$!&V:D0OE3"3%TJ*@F.-2'L:Z=Z(7&7$ XF7E7.S<\E8
MY4$:@1")3&:PPPQJIRBVHT?H=F"(/25OR;($"/[(PL*P\-A7:-X^\76]13W8
M[)(N7;GF:R]A2RZRJR8TFDY5+!@+QB9@=RH%=BQUD'C.)&3A8^YA=-C@##6*
MOS&&S;GDK0A#3?7%YD"XUC'Y*W3 51P'31RI@V['5>I&\X+\(37E+I'@2UOC
M)5W-8[+<*:"L=Z(2]:>4L%R!*-HYQ<M@9L58HGW2$'3.>?HXE(G#*42?PFS"
M=1;M19F7+]I39.DD*U)Q.'!/A0\&T5(C]96:O]L9"4BHAJWV-"V9I0[*27%^
M:<L$1/KHP/=5DJ>NX *5U-8<I=$U@\[KW,C0+<9CV39U06K]E$G>JR7X\C+#
M%!W[\1(57RI6(AN,,W%[+_3(JUS[9 HE 5T=!W'1,Q-,L_! * 7_]';O(4@W
M]EO9+E7U2-V2S 8,)&(ND[W5(=>3H/&B [U([7#3,/*,8V5 -F6)!*(Q-4>8
MV\$8@$1HGY%)@:J;<7B9KT$9# GQO1$0\F&6-3-0NNBEV^FQ!Y. XCDURO^)
M%REFW$&& 8?MFF(IC"X,L<%7&J%_9V4/7X7[?PL";>-2^HP\RH)'Z%4G :>Y
MC@@O6O E^79@^-'-QVO+ 2!->.$HUV%P4[HCW"ZN#45&7[,"X;<^3GTU*?+Y
M>"*\R^_CX%792A7MDI(SKU:UI4.HUP77UH/;8E<#+XLPA&S(JT_$T^D#W)A\
M@/)=MZ0!Q8!*LQQL4;F2W*NV)AA#[&XABH(PSXK.%^[G. <-8Q11(DI9 NNU
M;H&BH!P4W&,I->9\1FZ':[,#'3-(/Z/;<;3(*C)\W"1UUC(J729G(PNZX+86
MS?"9ZA@+V! (%OA>0<@+S8 %OG:L,@2'M/5WA-2LQCG14E67PA@_$.<'2F#Q
M?D2%C\Y>AX_ =LL<=>9L?9T:2BP2>7ZS:P10ZM*6 &9PSL;EL75/)%$3/).P
M336H[385+K(:(OE*!JD#?RI"A8XW56/.L"627BE=UM.(:L*0^QUAZ355VQ5#
MZ:+DJ#QJA,=.FF@^P#P%9\DB"B.IW(6AIM)7U#*:4D/>H@9*18VBN: W;)#'
M"YWF]RM<T3).AAKF'R4:.N/TAH:^LJ4R?:Z&;)",^5JRDND@JK;H?3O&_G=2
MIAU3L 0T3N9OCH^'=4UN#B,]19 T,Q>)1B? +$O*6MHPQ$-I-T7&W8Y?%]0F
M+U=?$4Y0,Y=$$[EW6R0O+&SE)'B5& ]CR5V"-\%_4="MN%7?!>FOCH[^?1\=
MW6!T]._[Z.@^.KIK7D^!B_T?AX%:V$J@\-*TNP,C)]-*+KF^3'A0 TZ ;H1(
M#D-E$-(PE%',@-.W!R]M\K(!.:'JL-5-8;0)\D[[1(YTZY>]4WI+EF6!;JN"
MB:ZTX79MC@T_9?EUJN*Q*JT14;>$AI([=:,E(&W9J\!F](:VI8 N+]*I=1@;
M1NRH1A99R&8;=>HKG.GK;  "SP(C,9>R(,+S8Z>8P@93J6NFI]%UN:?9+5G6
M6*=S9N1FX@C_V><9-O@5ZGV#E2SS@HDO5C _=%=H4)\T(LW5@@!96K5A6UMQ
M*_2,U;&.DT)J[;!232"7HD#FH],(^$4ZT?.:F^&H7^=Q,G1S1?]2E)@/61IH
M.VH#4K+7'3T%JER2DRG9YYHAVR9=3GI$.X,.ZWTX\#*QP8^[B1<>!D'('MBD
MTE0&+70SI!6M7T+=5X?M)'9Q4V(_(PX%<32-QJJLY=6W6#=8?NM#L;&10ZX6
M<C49N>4$M6BN5X@PQ7&$LF+?E1(*<3V*Z"1#+D.[2C[*T(N_2(E4*4<$K(-@
MCS.#B#S1M02S&:63D'B48#L_B0DRP-O\4F2"'4QU-T"+]E &\=PIVI&B9C8)
M+1&Q<#=$P,!_RXG'DO*>Q6W)LCQ$9@U?;O"^0HJ[J=+R%I"7W'?'0HJQT]AV
MZC9]&//"@3QL@/(V;B$!D]D?+%$*72"RO6ZX&\L23)U7MN\LG.FKQ,.L>),[
M@D#[E\011K50-EX1 8<F<+DK$]CVF>(RL#8NK==T5$N?%-<T\$2@?PGT:+B^
MD1=>0$&97"6I&EN\0BU[6([@_8#'2P/!D^K%FHK>EZ:LW(\&<Y,[66FC$?OJ
MTH[0=&<B\68'31C.M6B&9BFD A\-X4HF>W2?[5W6K]K^8E%=M[WH+ND&V<S%
M4>RWXALZ:#$ZRQ H!"P;5V'!BDP"KD2]F/4P-J2:J*D,\3&LAQZMKG%C=@MU
M@A63$2Z$8IQ?T?[8EZY3'V,06]2G M5,4-/X(FO<*TR)-KH4KHIU-"Y&0D\>
M7!OXU.9P-]NR>7$H@3[6\\M9<1=64A$:)U\\>AFB@&8<DW,B I30T;9'G*["
MVA<!A&$&#:_66>G^AF[)LCY)%K%N1<C&Q!$ADY0-0#DG<:KF7@B;9.A()VJ=
MX@00;7]@H571Q9),+%;\K30C9+%#U#5@H&SKA"G]:5N-D*%5&@CI>EHW_8Y,
M3=T ]?*&&U<H\C]FL=%$M?ST5K PTK5>(=YZB:UV*LY.VO4&Y),5N;[FL+^
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M<VCJTG'IZ\&!-Q*9KJ%,V,^!HZGE_P=02P,$%     @ 3# B6]&W6OS!&P
MZ1T   \   !F;W)M."UK7S P,2YJ<&>=6&E8$^F6+@0%045VEV[3C0M(%*X*
MHHA)NR *%].@@("0;FD$1$RK["0I-Z !D6LKT$!+$ 1DC:P1""G9!1H1$) @
M!(+(&I*P) 5)JJ:<9Y8?,\\S]\Z7.K^^JB_G/77.>]Y3Z$=T%-AL=^;<&4!)
M20GX"?L!Z!!P"E!>L^;KA2T5[%JKMG:MBLI:=575=6H;U#=LT%#7T-BX27OS
MQDU:FS0T-NMOUM+1U=/3VZ!IL$5?=XNVKI[NUT.4E+%G5-:N7[MVO>Y&C8VZ
M__)"WP!::D"HDJFRDB&P1DM)64L);0)P *"T5NG?%_ ?2VD-YN,Z5;7UZAK8
M#96;@35*RLIK5)2_>HWMTK!]0$5KK?;W!TZLTW'\6=7PIN[!NX^?J^T\65JO
MY]0MVG7HRJU[Z]7U#;9LW;9[CY'Q7A-SB\.61XY:G3IM<\;V[#F["Q>=75PO
MN;E[_^)SU=?/_]KMH."0T+#PB/L/HJ)C?HN-^_W)TZ3DE#]2T[*R7^3DYKW,
M+R@KKZBL8KVNKFEH;&IN:7W;UM[3^Z&O?^#C('>,/_YYXLODU/2,>&%Q:5DB
MA5=6O^)2 I25_G/]K[BT,%QK5%24552_XE):$_KU!BV5M=\?6*=]PE'UYYLZ
MA@?OJNF>?/R\M'[]SD-.(KTKM[K5]7>9C^T6?X7V[\C^.6#W_E_(_@O8?^/B
M AN4E;"7IZP%$ '%A:PX8^"KO3"_&@?DE!'G>V?J.O]R^=7Z2<6/>=+APD=]
M=',8?Y*6DH'O&:7,KTR[1VY+XJC=_B;X@.ZK5><_KX1&IL6$((+P7X@5B8U'
MTZ][F?:&@FR>W"'(RK4)T@P8(I9;=!)0 !2=LA)FY6IJD4;RU]LBPX^3K!M5
M78?S7 ZB "L;\0VU,7SU\S].9%ND3L7;[/'W _[3LW_!UD =$ST^,:(?K8I_
M10%M9)<_69U--&46=BPH/F:1(#P8[)=S/L>_)<EXT<YV=\32JZ4<EZ)J;QWO
M)L*N7NO=.1V%,]+WE_PELXOV^.MV*Q?X9 $SR">YM5X?OX%\6W9^.?0&"MPR
M0TS9Z4W(87&,8.OXELQ'1Y>-AI'XO"'Y*RY3B@*RP\P@$6.N<8RL['\S@*=5
M:<S<$TL=#&4E^1O(< +7*?.#['6.6SH.*B;<:'\P4OF'BAJMGN;[@+7/<7$O
MZGBSBX3 #^Q3X^0XJ2RGNH]]ZE=>O?[D:12X8]:>]-Z?7#;0E!!HR8S9%8-P
M3)/-%!EU\4TH4&4;P\933%-'S31/'+19H)7XR([7@#7QBY;(,2]* =)#UK>^
M&/+Q4]?&0L6'W@H44*1?G5F-.\+N<50TJW4G2J$VW$Z/C4D%#,&1M*09,%0^
MF 3*]E(=RLD'J 2F@73_?!:HR&"C@)?(-Y:ZFRC_^U+QR49?,7L#!"M"!XC:
MA(-^@LF.?/BQCJ+6!7/W/9[LH& BWPTRRF<$WD4GY(YDMRPL?AQ\S;/+?,*B
M)!ALW /]-9I_:J_7C.0IU*R+ FU_,N\0CL-=;[3S/E)/'>,:C51P4.!L/ KL
MD$$B]=7$L43!W4R8>ZE"$>[:R$VGQLT/"28H$AP,C@:/#9B)RL?W#?G<1_1:
M8R=D)9#%TV*D%]1$CGKYC$/1[EV-^]WV!?_1KYLR>6]^S[#NK&+YVB)^]."G
M$:^&.C,?\NK*H;[&JVZY=G7%ZAQN(J("O3.:L;)Z&]>YR)3.O)TFX^G-&2;]
MP0DX]][E]9^K>RNFKW@<BTVG#_/H^U&@F7QAYQ<3.0-W+UE99Y]Y3F<[O2]I
MW#OUYYWQCA-?]G7;Z+5$/+?1_5'IG[>8'."G&6Y454)N5S#-<&CPA$X'GB4R
M''BSPUJ\AR4[1W5FW;=W([Q;J' /?J)X:X@<):/ R6M2LR%[_JDI9'.9Z%G"
MNQL6OKS;I570/R#Y!7#*HE1F)#>M$N'ND)MJ[JU89;SD!%!0(%D?!=XP9!:T
M7->.IZ,YJ>>)=2FU?Y?W6@8?^I-Z*\UI(D<S(@\%=BKHT1G/LF%7B1,<+FGK
MVU,;/'2\I6LI?@6L)1_+31%K2LK%WN=18"IB-QNBH<!XSX"B2UCI1^84RMSD
MOT:>-4H>:ECUH)8P;EY!L&+I\AQHUOSMT+2!"T.-H'UIQ=*/X]S9#,G+D-4;
MB#ZR.% 8\T!T0SC2;#_R-$?4&_N9;V2[5<,L5(,T_-!;?/&QBR=^E#>WN-/=
M\_3(07$0^<W,HRD46%4AK^IYYPE<QXO#V8EJL)7&$=?Y1KTB%@Y>G7.?*B)L
MIEHI&!47!ZS!R!UUQ?:+!>W%)N;04KL9'P7""Y99+8Q8^D$'2).#VQ^=5"[5
M(9LV4:2$F0'K J<B19Y9%0KD)>WNP,E"OI^;M+EU.Q*W&FIGW8M1V8M?5QD"
M'7%ZX_27F9IU;R'H9H[5;E<25Z>!8'U_CK=9KAI8"GTQRI.7,9%.%$@<R 0;
M*++34_&2>.$F?ZD$:M9CVPE1X%$==E"360S.X ;CC'@R!AK;(%XG8'"K1-=M
M0 D6.*OYO&UZM,F81#C??B1145O=Z>X\/E]TNDY8[K)C#A(('I%;H/)/EJL!
M<.&8Y 7'2+1JNC)&@F7W$64Y%IU >A=R.';I64AKZ^]<H\8$4\W#'M#FLN*Z
M/VN1BRXI,A0@=B"=;N\YWP;PRHF_E<@#2P+^YB8_WIL962APWVJY@CGQ)L-U
MY*KO+R5$25*O !K-@I279%UW5PM'B#$6+I&"30)Z\V1Y'H_&,YU <-(1]E]=
M1RIQ!;<CSW:,I7 3Y;C:OR0'+\<,72%4&[<GFM4:*U+!F [A@G4\HA[.IVA-
M0Z([8 ,+R\\HEL1L?W%K]"]#_C>#H2\K?%DGRX?&0@$521\5+$0ZD&W5<(RD
MS<*S)^=/5BVG>W\&"@Q;UW(">2"B5%8*C3)XY:ZQD"_CGBO]6_%X?>A+\LS^
ME^#579!?=&=(UAPR+WP2VD;V -=2S?/VRFVG10_VMOZN/)45=Z\ASCASS?]I
MY_L8O@4?9SPX;:$;O_#J/K<SJ^Z8^V7% 7LU3]D[@*]Y=BI+MF^(NH$3<+G,
M9<_C10=_O<\N18SA.+-4%)!$K.I(\L44^7<\56%@,<<^79&L/T2\"R:BP+?N
MXL3!< ,RO,S?& %F7$I><$:!N_95-2@P9'>UWX(44V,F+V-S:#SI)WL4*!^8
M^N./"\D^#^KMQ_*VH,"T->_YRJ9MU&HOR^VXN(H<G#P]91D/;^-JWH'*+W,7
MFC_/KKXX9[)3@0*'R<OG4  @I540-ONY@V]X#PSH1\2XKN*1>DGL, KTRWDS
M661)6@G2VW]@AK,;)H\=0>SMATG2?*1]CJQ0I@7*KW>G-&<<A8-'A;4^P=0!
MUN/K*U[&.K>,D ZOB[.RL%8NV#%M=PL%-M#;IGHS7_6F&,D;6\RG46"@3>XD
M/Z]L)UI.B$ZY*;[ C[1XQPIFS5G9-]=]-XP4[(Z'TVJ-K0^)=_(Y0P+?RQ2E
M:>+";*[_WIIQBL(B1<:;ZY>G7<^P@(="!MJS[43%1?9ZM7(,_P7Y$ J,[O4J
MWW8BEYME.&?#--))>!K^2[80_%R:..CX:.A&%T4Y:>3@A:=U#$M%W5%:WEX*
MYZTH%?(E;IXF23I5^;Z_:0L(,V1B6B*R?'/']Q7W+[VJN3^>DQ 3\WO]A79Q
MS?FJTL.3'Q]3D#W@O&LW_:BX*X:PU8_"Q^E=J^+N>:*;K^,Y7/7!Q9>;Q,_X
M'B8RZ3WZ="L1LX6DZ4\9M?D@F&<?.IQ(;;MI;0]-AB"X%%^%9#G*N@=2U$E\
M1&VT?OGYZ<^O W@C$S)'. MQ@D8JK1<;(RA-T$-(AQHIBFS=H7P1WL2]S9U.
M:X8Z.+L&)>%7&*%"MZ\$:S%/+B?-58\1![T;TJ)CQERJJV6T+FY)"3/5W8T\
MGS<L*ZB<C3"-]1T3&+;:]?(W#U[Z(5ETDM&HO>>#W6#)^HZ,RZW=)P\\"/^.
M$&<2U?>7BTO7\;_B]=C7.G>5##F[9)8I]%82 L4DOE"NB\?8\S<Y4<1KUI$?
M@XF9[6)2T<=Y^_@NQN= %(B\/?<I=D'@OG3\%++^&?^8!E@QA:L@)@HJ+8XE
M"4O2+D'"J A QHV#\[!SZG$/K5SG @ZGXIKJ+CC!26.Y#"=/7U(2G^:T-I12
M#HG! A1H[:DE?E25)*- ]$-8+^_3C '>\N&20]J-BD3I<,H\5@[*)'ED,$"S
MM:'N%8_S8^(1 M)/V ;O%O&\..^#2)L@2<S#RLZ#GH\PC4&006*>E*=(FT4!
M"I';OB@)%$7'9L'GN<?M6S.^!\NG702+*QI2:C^)OY+J#'(S-9G&S"ZB&ATK
M;/K.:?U5:3/C$;(_IHEE_Z4C;VK XWO6)\9M62WTR4[(4:>WDG60=7+W[N5+
M'(M9@JGH]#D3GE_$4'N7Z40@U-(AG5*>F\$ORL8'FG'Z?CR14^(#SN9>]JE\
M-_@:PC6JZ<EZ]OM(B$(X0H+57:<V KJ.Y#\8HHM,+K%UFV833A-6'LNM+/!W
MC3B?:EI91$C [UQQD%H*$-W3/"P.F9J]-?@&%/#N>E@JIRJ>L;?S0YZ96AB5
MVWN2OJSTSYC][HD"0JQCP]\Z*5Y!_@E$B0=\/)0?_M.]18\:2MG4*K6KO.L9
M5(>T*[YD:F;Z,;'V%4TN ULH7+"Q*N,(7"@&FY M@6[T/M],. (L5V3LD=4^
MF6=VR/6X,"C1@AE8RM>85HY1N,I-:<F/URXY\?RX2V4=DV^8BUF')0A.8JP\
M7X-?'$+4$\918"M,=(//Y839-J_F18$LBZW72W)Z)_U8\V&/MT)UK. @G.@-
MS@"<FI)[HP 5PI@R4[/&C_D8!?QK*7I45<5=MO.&'0<^5)KI^87\S1!.\QT*
MQ5?.D0^C@)3L$X("KR9C@\E;D790TZ(S]$>&<Q]EG]MD;77@0CO/+XD>BI@
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M"(B]4D%>N38CD>D@:[V>^\I\Z>]U/&V^@<J^U&[X>SM&,M=E$#P1+I3K/9;
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MV[- 3E:<[T]?&^F_:$KHX+\!4$L! A0#%     @ 3# B6_UD=-W! P  O@X
M !$              ( !     &-Y8V,M,C R-3 Y,#$N>'-D4$L! A0#%
M  @ 3# B6_-Q9^'U"   96@  !4              ( !\ ,  &-Y8V,M,C R
M-3 Y,#%?9&5F+GAM;%!+ 0(4 Q0    ( $PP(EO &E-7Y0L  -&/   5
M          "  1@-  !C>6-C+3(P,C4P.3 Q7VQA8BYX;6Q02P$"% ,4
M" !,,");1H[9KT (  #_8@  %0              @ $P&0  8WEC8RTR,#(U
M,#DP,5]P<F4N>&UL4$L! A0#%     @ 3# B6[,7N<AE.P  A9H!  H
M         ( !HR$  &5X,3 M,2YH=&U02P$"% ,4    " !,,");UHTIQ%\[
M  !^F@$ "@              @ $P70  97@Q,"TR+FAT;5!+ 0(4 Q0    (
M $PP(ELPW*+;7CL  'B: 0 *              "  ;>8  !E>#$P+3,N:'1M
M4$L! A0#%     @ 3# B6ZH) @&7%P  J;H   L              ( !/=0
M &9O<FTX+6LN:'1M4$L! A0#%     @ 3# B6]&W6OS!&P  Z1T   \
M         ( !_>L  &9O<FTX+6M?,# Q+FIP9U!+!08     "0 ) "8"  #K
%!P$    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>form8-k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:CYCC="http://cyclacel.com/20250901"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="cycc-20250901.xsd" xlink:type="simple"/>
    <context id="AsOf2025-09-01">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001130166</identifier>
        </entity>
        <period>
            <startDate>2025-09-01</startDate>
            <endDate>2025-09-01</endDate>
        </period>
    </context>
    <context id="From2025-09-012025-09-01_custom_CommonStockParValue0.001PerShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001130166</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCC:CommonStockParValue0.001PerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-09-01</startDate>
            <endDate>2025-09-01</endDate>
        </period>
    </context>
    <context id="From2025-09-012025-09-01_custom_PreferredStock0.001ParValueMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001130166</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCC:PreferredStock0.001ParValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-09-01</startDate>
            <endDate>2025-09-01</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2025-09-01" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2025-09-01" id="Fact000004">0001130166</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2025-09-01" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2025-09-01" id="Fact000010">2025-09-01</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2025-09-01" id="Fact000011">Cyclacel Pharmaceuticals, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2025-09-01" id="Fact000012">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2025-09-01" id="Fact000013">0-50626</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2025-09-01" id="Fact000014">91-1707622</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2025-09-01" id="Fact000015">Level 10, Tower 11</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2025-09-01" id="Fact000016">Avenue 5, No. 8</dei:EntityAddressAddressLine2>
    <dei:EntityAddressAddressLine3 contextRef="AsOf2025-09-01" id="Fact000017">Jalan Kerinchi</dei:EntityAddressAddressLine3>
    <dei:EntityAddressCityOrTown contextRef="AsOf2025-09-01" id="Fact000018">Kuala Lumpur</dei:EntityAddressCityOrTown>
    <dei:EntityAddressCountry contextRef="AsOf2025-09-01" id="Fact000019">MY</dei:EntityAddressCountry>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2025-09-01" id="Fact000020">59200</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2025-09-01" id="Fact000021">(908)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2025-09-01" id="Fact000022">517-7330</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2025-09-01" id="Fact000023">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2025-09-01" id="Fact000024">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2025-09-01" id="Fact000025">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2025-09-01" id="Fact000026">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="From2025-09-012025-09-01_custom_CommonStockParValue0.001PerShareMember"
      id="Fact000027">Common Stock, par value     $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2025-09-012025-09-01_custom_CommonStockParValue0.001PerShareMember"
      id="Fact000028">CYCC</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2025-09-012025-09-01_custom_CommonStockParValue0.001PerShareMember"
      id="Fact000029">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="From2025-09-012025-09-01_custom_PreferredStock0.001ParValueMember"
      id="Fact000030">Preferred Stock, $0.001     par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2025-09-012025-09-01_custom_PreferredStock0.001ParValueMember"
      id="Fact000031">CYCCP</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2025-09-012025-09-01_custom_PreferredStock0.001ParValueMember"
      id="Fact000032">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2025-09-01" id="Fact000033">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
